{
 "cells": [
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Authors: Phu Dang and Diane Dinh\n",
    "\n",
    "Purpose: Pedal ROI Data Analysis\n",
    "\n",
    "Date: 05.11.2023\n",
    "\n",
    "Number of projects per investment pillar (AG-AK) (Phu & Diane) \\\n",
    "Name of project title and clinical trials(DA-DG) (Phu & Diane) \\\n",
    "Number of peer-reviewed publications (DM) (Phu & Diane) \\\n",
    "Name of project titles that will lead to improvements in health policy (FD, FL) (Phu & Diane)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Importing libraries and packages\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np \n",
    "import matplotlib.pyplot as plt \n",
    "import seaborn as sns\n",
    "import plotly.express as px\n",
    "import os\n",
    "import re\n",
    "\n",
    "# pd.set_option('display.max_rows', None)\n",
    "# Adjust dataframe display options to view full output\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.width', None)\n",
    "\n",
    "# Reset to default ~ comment 2 lines above and \n",
    "# uncomment 2 lines below, run all before pushing to GitHub\n",
    "# pd.set_option('display.max_columns', 20)\n",
    "# pd.set_option('display.width', 80)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Read datasets\n",
    "\n",
    "os.chdir('../data')\n",
    "fp = os.path.join('interim', '2022_Pedal_Progress_Report.csv').replace(\"\\\\\",\"/\")\n",
    "pr = pd.read_csv(fp, index_col=0)\n",
    "\n",
    "fp = os.path.join('interim', '2022_Pedal_ROI.csv').replace(\"\\\\\",\"/\")\n",
    "roi = pd.read_csv(fp, index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0  3.0  Progress Report #1                  NaN          NaN   \n",
       "1  4.0  Progress Report #1                  NaN          NaN   \n",
       "2  5.0  Progress Report #1                  NaN          NaN   \n",
       "3  6.0  Progress Report #1                  NaN          NaN   \n",
       "4  8.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "  Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                  NaN         NaN                  NaN         NaN   \n",
       "1                  NaN         NaN                  NaN         NaN   \n",
       "2                  NaN         NaN                  NaN         NaN   \n",
       "3                  NaN         NaN                  NaN         NaN   \n",
       "4                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "  Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                  NaN           NaN                  NaN          NaN   \n",
       "1                  NaN           NaN                  NaN          NaN   \n",
       "2                  NaN           NaN                  NaN          NaN   \n",
       "3                  NaN           NaN                  NaN          NaN   \n",
       "4                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                  NaN         NaN                   NaN         NaN   \n",
       "1                  NaN         NaN                   NaN         NaN   \n",
       "2                  NaN         NaN                   NaN         NaN   \n",
       "3                  NaN         NaN                   NaN         NaN   \n",
       "4                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                 Pedal Non-Peer Pubs  \\\n",
       "0                                                NaN   \n",
       "1       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                       None to date   \n",
       "3                                                NaN   \n",
       "4  8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "\n",
       "                               Other Accomplishments Health Benefits  \\\n",
       "0                                                NaN             Yes   \n",
       "1                                                NaN             Yes   \n",
       "2  additional funding provided by Padres Pedal th...             Yes   \n",
       "3                  See above in the progress report.             Yes   \n",
       "4  2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "\n",
       "   International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0          False     False  False           False                     False   \n",
       "1           True     False  False           False                     False   \n",
       "2           True     False  False           False                     False   \n",
       "3           True      True  False           False                     False   \n",
       "4          False     False  False           False                     False   \n",
       "\n",
       "   Patients  Patient Families Policy Influence  International (pol)  \\\n",
       "0      True             False               No                False   \n",
       "1     False             False               No                False   \n",
       "2     False             False               No                False   \n",
       "3      True              True               No                False   \n",
       "4      True             False               No                False   \n",
       "\n",
       "   National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0           False        False                 False   \n",
       "1           False        False                 False   \n",
       "2           False        False                 False   \n",
       "3           False        False                 False   \n",
       "4           False        False                 False   \n",
       "\n",
       "   Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                           False           False                   False   \n",
       "1                           False           False                   False   \n",
       "2                           False           False                   False   \n",
       "3                           False           False                   False   \n",
       "4                           False           False                   False   \n",
       "\n",
       "  Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                         NaN                No                 False   \n",
       "1                         NaN                No                 False   \n",
       "2                         NaN               Yes                 False   \n",
       "3                         NaN               Yes                  True   \n",
       "4                         NaN                No                 False   \n",
       "\n",
       "   National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0            False         False                  False   \n",
       "1            False         False                  False   \n",
       "2             True         False                  False   \n",
       "3             True         False                  False   \n",
       "4            False         False                  False   \n",
       "\n",
       "   Healthcare Professionals (econ)  Patients (econ)  Patient Families (econ)  \\\n",
       "0                            False            False                    False   \n",
       "1                            False            False                    False   \n",
       "2                            False            False                    False   \n",
       "3                            False             True                     True   \n",
       "4                            False            False                    False   \n",
       "\n",
       "                       Economic Benefits Description Equity Benefits  \\\n",
       "0                                                NaN              No   \n",
       "1                                                NaN              No   \n",
       "2  The combination of cabozantinib with 13-cis-re...              No   \n",
       "3  Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                NaN             Yes   \n",
       "\n",
       "   International (equity)  National (equity)  Local (equity)  \\\n",
       "0                   False              False           False   \n",
       "1                   False              False           False   \n",
       "2                   False              False           False   \n",
       "3                    True               True           False   \n",
       "4                   False              False           False   \n",
       "\n",
       "   General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                    False                              False   \n",
       "1                    False                              False   \n",
       "2                    False                              False   \n",
       "3                    False                              False   \n",
       "4                    False                              False   \n",
       "\n",
       "   Patients (equity)  Patient Families (equity)  \\\n",
       "0              False                      False   \n",
       "1              False                      False   \n",
       "2              False                      False   \n",
       "3               True                       True   \n",
       "4               True                      False   \n",
       "\n",
       "                         Equity Benefits Description  \\\n",
       "0                                                NaN   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3  At risk oral cancer patients are often part of...   \n",
       "4  Trial focused on all demographic of prostate c...   \n",
       "\n",
       "  Additional Funding Achieved First AFS Status  \\\n",
       "0                         One          Awarded   \n",
       "1                        Five          Awarded   \n",
       "2                         One          Awarded   \n",
       "3                         One        Submitted   \n",
       "4                         One          Awarded   \n",
       "\n",
       "                    First AFS Name and Project Title  First AFS Amount  \\\n",
       "0  NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                            the Hartwell Foundation          300000.0   \n",
       "2                                     Exelixis, Inc.          250000.0   \n",
       "3                NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                         Oncternal           377000.0   \n",
       "\n",
       "  Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1           Awarded            Padres Pedal the Cause           100000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0              NaN                                   NaN               NaN   \n",
       "1        Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2              NaN                                   NaN               NaN   \n",
       "3              NaN                                   NaN               NaN   \n",
       "4              NaN                                   NaN               NaN   \n",
       "\n",
       "  Fourth AFS Status Fourth AFS Name and Project Title  Fourth AFS Amount  \\\n",
       "0               NaN                               NaN                NaN   \n",
       "1         Submitted                NIH R03CA273629-01           150000.0   \n",
       "2               NaN                               NaN                NaN   \n",
       "3               NaN                               NaN                NaN   \n",
       "4               NaN                               NaN                NaN   \n",
       "\n",
       "  Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                NaN                   \n",
       "1                   Tower Cancer Research Foundation                   \n",
       "2                                                NaN                   \n",
       "3                                                NaN                   \n",
       "4                                                NaN                   \n",
       "\n",
       "  Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0              NaN               NaN                             Yes   \n",
       "1        Submitted          500000.0                             Yes   \n",
       "2              NaN               NaN                             Yes   \n",
       "3              NaN               NaN                             Yes   \n",
       "4              NaN               NaN                             Yes   \n",
       "\n",
       "             Additional Funding Benefits Description  \\\n",
       "0  Additional funding would enable the applicatio...   \n",
       "1  Additional funding support would allow us to p...   \n",
       "2  Additional funding support would allow us to e...   \n",
       "3  For advancing the planned clinical trial and c...   \n",
       "4  This is a grass roots project. It is a single ...   \n",
       "\n",
       "  Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                               Yes   \n",
       "1                                               Yes   \n",
       "2                                               Yes   \n",
       "3                                               Yes   \n",
       "4                                                No   \n",
       "\n",
       "  Additional Funding Benefits Description (clinical stages)  \\\n",
       "0  In addition, funding could allow us to do more...          \n",
       "1  Additional funding support would allow us to p...          \n",
       "2  Additional funding support would allow us to p...          \n",
       "3  Identification of biomarkers predicting clinic...          \n",
       "4                                                NaN          \n",
       "\n",
       "                               Participated in Pedal  \\\n",
       "0  Yes, I have participated as a rider every year...   \n",
       "1  I have participated as both a virtual particip...   \n",
       "2  I have participated as both a virtual particip...   \n",
       "3                                                Yes   \n",
       "4                                      Yes, runner.    \n",
       "\n",
       "  Further Research Contributions Success Stories  \\\n",
       "0                             No              No   \n",
       "1                            Yes              No   \n",
       "2                            Yes             Yes   \n",
       "3                             No              No   \n",
       "4                            Yes              No   \n",
       "\n",
       "  Major Scientific Breakthroughs  \\\n",
       "0                            NaN   \n",
       "1                            NaN   \n",
       "2                            Yes   \n",
       "3                            NaN   \n",
       "4                            NaN   \n",
       "\n",
       "                                 Additional Comments  Complete  \\\n",
       "0                                                NaN      True   \n",
       "1  Funding from Padres Pedal the Cause has been i...      True   \n",
       "2  Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                Many thanks for all your support!!!      True   \n",
       "4                                                NaN      True   \n",
       "\n",
       "  Publication Status 1 First DOI # Publication Status 2 Second DOI #  \\\n",
       "0             Accepted         NaN                  NaN          NaN   \n",
       "1             Accepted         NaN            Submitted          NaN   \n",
       "2            Published         NaN                  NaN          NaN   \n",
       "3          In progress         NaN          In progress          NaN   \n",
       "4                  NaN         NaN                  NaN          NaN   \n",
       "\n",
       "  Publication Status 3 Third DOI #  \n",
       "0                  NaN         NaN  \n",
       "1                  NaN         NaN  \n",
       "2                  NaN         NaN  \n",
       "3                  NaN         NaN  \n",
       "4                  NaN         NaN  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>3.1</td>\n",
       "      <td>Detecting dysregulated genes in neuroblastoma ...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Identify genes that are dysregulated in neurob...</td>\n",
       "      <td>Identify and characterize de novo germline and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Improved knowledge of the genetic mutations th...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2021-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PPTC funding allowed a postdoctoral resear...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>4.1</td>\n",
       "      <td>Functional Roles for Histidine Kinase Signalin...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Evaluate the functional role of NME1 expressio...</td>\n",
       "      <td>Evaluate the functional role of NME1 histidine...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2019-07-15</td>\n",
       "      <td>2020-07-14</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>5.1</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the safety, dose-limiting toxicities...</td>\n",
       "      <td>Identify biomarkers predictive of patient resp...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with high-risk and recurrent solid tu...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2023-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>8.1</td>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>To investigate the safety and tolerability of ...</td>\n",
       "      <td>To evaluate the anti-tumor activity of cirmtuz...</td>\n",
       "      <td>To prospectively interrogate the Wnt signaling...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic castration resistant prostate cance...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2020-01-01</td>\n",
       "      <td>2021-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes this grant was supporting the infrastructu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Zero</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    ID Event Name  Award ID  \\\n",
       "0  3.0    Initial       3.1   \n",
       "2  4.0    Initial       4.1   \n",
       "4  5.0    Initial       5.1   \n",
       "6  6.0    Initial       6.1   \n",
       "8  8.0    Initial       8.1   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  Detecting dysregulated genes in neuroblastoma ...        Salk Institute   \n",
       "2  Functional Roles for Histidine Kinase Signalin...       Rady Children's   \n",
       "4  A National Phase I Study of Cabozantinib in Co...       Rady Children's   \n",
       "6  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "8  A Phase 1B, Nonrandomized Trial Investigating ...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "2               NaN                            False   \n",
       "4               NaN                            False   \n",
       "6               NaN                            False   \n",
       "8               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "2                                           False   \n",
       "4                                           False   \n",
       "6                                           False   \n",
       "8                                            True   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "2                                      False                          False   \n",
       "4                                      False                          False   \n",
       "6                                      False                          False   \n",
       "8                                      False                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0               True    Two Specific Aims   \n",
       "2               True    Two Specific Aims   \n",
       "4               True    Two Specific Aims   \n",
       "6              False  Three Specific Aims   \n",
       "8              False  Three Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Identify genes that are dysregulated in neurob...   \n",
       "2  Evaluate the functional role of NME1 expressio...   \n",
       "4  Determine the safety, dose-limiting toxicities...   \n",
       "6  Improve outcomes for HNSCC by expanding our un...   \n",
       "8  To investigate the safety and tolerability of ...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Identify and characterize de novo germline and...   \n",
       "2  Evaluate the functional role of NME1 histidine...   \n",
       "4  Identify biomarkers predictive of patient resp...   \n",
       "6  Leverage our administrative, biostatistics, co...   \n",
       "8  To evaluate the anti-tumor activity of cirmtuz...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "4                                                NaN   NaN   NaN   NaN   \n",
       "6  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "8  To prospectively interrogate the Wnt signaling...   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Improved knowledge of the genetic mutations th...      100000.0   \n",
       "2  Children with aggressive neuroblastoma have po...      100000.0   \n",
       "4  Children with high-risk and recurrent solid tu...      200000.0   \n",
       "6  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "8  Metastatic castration resistant prostate cance...      150000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2019-07-15      2021-07-14  Complete      True   \n",
       "2        2019-07-15      2020-07-14  Complete     False   \n",
       "4        2021-07-01      2023-06-30  Complete     False   \n",
       "6        2021-07-01      2022-06-30  Complete     False   \n",
       "8        2020-01-01      2021-12-31  Complete     False   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                 False   \n",
       "2                   False                                 False   \n",
       "4                   False                                 False   \n",
       "6                   False                                  True   \n",
       "8                   False                                  True   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                           False   \n",
       "2                   True                           False   \n",
       "4                   True                           False   \n",
       "6                  False                            True   \n",
       "8                   True                            True   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                  False   \n",
       "2                   False                                  False   \n",
       "4                   False                                  False   \n",
       "6                   False                                   True   \n",
       "8                   False                                   True   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "2                    False               False                       False   \n",
       "4                    False               False                       False   \n",
       "6                    False               False                       False   \n",
       "8                    False               False                       False   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "2                     False                                    False   \n",
       "4                     False                                    False   \n",
       "6                     False                                    False   \n",
       "8                     False                                    False   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "2                False                                  False   \n",
       "4                False                                  False   \n",
       "6                False                                  False   \n",
       "8                False                                  False   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "2                                   True                           False   \n",
       "4                                  False                           False   \n",
       "6                                  False                           False   \n",
       "8                                  False                           False   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "2                    False   \n",
       "4                    False   \n",
       "6                    False   \n",
       "8                    False   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "2                                                Yes       \n",
       "4                                                Yes       \n",
       "6                                                Yes       \n",
       "8                                                Yes       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  The PPTC funding allowed a postdoctoral resear...                   NaN   \n",
       "2  The availability of funding from Padres Pedal ...                   NaN   \n",
       "4  The availability of funding from Padres Pedal ...                   NaN   \n",
       "6  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "8  Yes this grant was supporting the infrastructu...                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted  \\\n",
       "0                       0.0   \n",
       "2                       0.0   \n",
       "4                       1.0   \n",
       "6                       1.0   \n",
       "8                       1.0   \n",
       "\n",
       "                                First Clinical Trial  \\\n",
       "0                                                NaN   \n",
       "2                                                NaN   \n",
       "4  A National Phase I Study of Cabozantinib in Co...   \n",
       "6           Metformin for oral cancer prevention 2.0   \n",
       "8  Phase 1B, Nonrandomized Trial Investigating Do...   \n",
       "\n",
       "   First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                 NaN                   NaN   \n",
       "2                                 NaN                   NaN   \n",
       "4                                 6.0                   NaN   \n",
       "6                                80.0                   NaN   \n",
       "8                                 0.0                   NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN              None            No   \n",
       "2                                  NaN              none            No   \n",
       "4                                  NaN              None            No   \n",
       "6                                  NaN                No            No   \n",
       "8                                  NaN         Oncternal            No   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              One  \n",
       "2            NaN                              Two  \n",
       "4            NaN                              One  \n",
       "6            NaN                              Two  \n",
       "8            NaN                             Zero  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "five_pillars = ['Prevention and diagnostic tools', \n",
    "                'Novel approaches and new therapeutic platforms',\n",
    "                'Immunotherapies and personalized vaccines',\n",
    "                'Addressing cancer disparities',\n",
    "                'Pediatric cancers']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "False    153\n",
      "True      37\n",
      "Name: Prevention and diagnostic tools, dtype: int64\n",
      "\n",
      "190\n",
      "False    123\n",
      "True      67\n",
      "Name: Novel approaches and new therapeutic platforms, dtype: int64\n",
      "\n",
      "190\n",
      "False    154\n",
      "True      36\n",
      "Name: Immunotherapies and personalized vaccines, dtype: int64\n",
      "\n",
      "190\n",
      "False    187\n",
      "True       3\n",
      "Name: Addressing cancer disparities, dtype: int64\n",
      "\n",
      "190\n",
      "False    143\n",
      "True      47\n",
      "Name: Pediatric cancers, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for col in five_pillars:\n",
    "    print(roi[col].value_counts().sum())\n",
    "    print(roi[col].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Prevention and diagnostic tools                   0\n",
       "Novel approaches and new therapeutic platforms    0\n",
       "Immunotherapies and personalized vaccines         0\n",
       "Addressing cancer disparities                     0\n",
       "Pediatric cancers                                 0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[five_pillars].isna().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "190\n",
      "190\n"
     ]
    }
   ],
   "source": [
    "print(len(roi['ID'].unique()))\n",
    "print(roi.shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0    174\n",
       "1.0     15\n",
       "2.0      1\n",
       "Name: Clinical Trials Resulted, dtype: int64"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Clinical Trials Resulted'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "value_map = {'No Trials': 0, 'One Trial': 1, 'Two Trials': 2, np.nan: 0}\n",
    "\n",
    "roi['Clinical Trials Resulted'] = roi['Clinical Trials Resulted'].replace(\n",
    "    value_map\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors                                                                               2\n",
       "Metformin for oral cancer prevention 2.0                                                                                                                                                                             1\n",
       "Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer                                                                     1\n",
       "Individualized therapy for refractory medulloblastoma                                                                                                                                                                1\n",
       "NCT05153304  Protocol PCV-001  A Phase I/II Safety and Feasibility Study of Personalized Immunotherapy in Adults with Upper Gastrointestinal Tract Cancers.                                                          1\n",
       "Trial Name:    Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor  NCT#: NCT03556384                                                                       1\n",
       "A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)                                                                  1\n",
       "Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NSCLC)    NCT04043195                                                                                        1\n",
       "Ruxolitinib with or without navitoxlax (Abbvie)                                                                                                                                                                      1\n",
       "Neoadjuvant Immunoradiotherapy in Head & Neck Cancer                                                                                                                                                                 1\n",
       "A Phase 1b Trial of Cirmtuzumab and Paclitaxel in Metastatic or Locally Advanced, Unresectable Breast Cancer                                                                                                         1\n",
       "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)                                                         1\n",
       "NCI10096 ClinicalTrials.gov Identifier:  NCT03317392  Title:  A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer with Bone Metastases (COMRADE)    1\n",
       "NIVOLUMAB (ANTI-PD1 ANTIBODY) AND IPILIMUMAB (ANTI-CTLA4 ANTIBODY) IN COMBINATION WITH IMMUNOGENIC CHEMOTHERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER                                                1\n",
       "Discovery and translation of precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) stem cell targets                                                                                                                 1\n",
       "Name: First Clinical Trial, dtype: int64"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[\"First Clinical Trial\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0      Detecting dysregulated genes in neuroblastoma ...\n",
       "2      Functional Roles for Histidine Kinase Signalin...\n",
       "10                    New Therapies for Myeloid Leukemia\n",
       "12     Peptide Targeted Delivery of Epigenetic Therap...\n",
       "14             Precision Interception of Gastric Cancers\n",
       "                             ...                        \n",
       "289    Identification of therapeutic targets of B-ALL...\n",
       "290    Identification of therapeutic targets of B-ALL...\n",
       "291    Developing targeted therapy for Ewing sarcoma ...\n",
       "292    Developing targeted therapy for Ewing sarcoma ...\n",
       "293                                              Science\n",
       "Name: Project Title, Length: 174, dtype: object"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['First Clinical Trial'].isna()]['Project Title']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dtype('float64')"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi.dtypes['Clinical Trials Resulted']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "71    41.0    Initial      41.1   \n",
       "187  118.0    Initial      41.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "71   An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "187  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "71                NaN                            False   \n",
       "187               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "71                                             True   \n",
       "187                                            True   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "71                                       False                          False   \n",
       "187                                      False                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "71               False  Three Specific Aims   \n",
       "187              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "71   Primary objective: To determine overall respon...   \n",
       "187  Primary objective: To determine overall respon...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "71   Secondary objective: To determine progression-...   \n",
       "187  Secondary objective: To determine progression-...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "71   Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "187  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "71   Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "187  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "71         2019-01-01      2020-12-31  Complete     False   \n",
       "187        2019-01-01      2020-12-31  Complete     False   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "71                    False                                  True   \n",
       "187                   False                                  True   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "71                    True                            True   \n",
       "187                   True                            True   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "71                    False                                  False   \n",
       "187                   False                                  False   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "71                     False               False                       False   \n",
       "187                    False               False                       False   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "71                      False                                    False   \n",
       "187                     False                                    False   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "71                 False                                  False   \n",
       "187                False                                  False   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "71                                   False                           False   \n",
       "187                                  False                           False   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "71                     False   \n",
       "187                    False   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "71                                                 Yes       \n",
       "187                                                 No       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "71   The PTC funding lead to preliminary data for a...                   NaN   \n",
       "187                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "71                        1.0   \n",
       "187                       1.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "71   Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "187  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "\n",
       "     First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "71                                 13.0                   NaN   \n",
       "187                                18.0                   NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "71                                   NaN              None            No   \n",
       "187                                  NaN               NaN            No   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "71             NaN                            Three  \n",
       "187            NaN                              One  "
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi[roi['Project Title'].str.contains('An Open')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Readjust the clinical trials name columns to plot in Tableau\n",
    "\n",
    "def adjust_cli_trials_names(data, title):\n",
    "\n",
    "    \"\"\"\n",
    "        df (DataFrame): subject dataframe\n",
    "        title (str): the title of the project to adjust clinical trials names\n",
    "\n",
    "    \"\"\"\n",
    "\n",
    "    df = data[data['Project Title'] == title].reset_index(drop=True)\n",
    "    num_trials = df['Clinical Trials Resulted'].sum()\n",
    "    first = df['First Clinical Trial'].reset_index(drop=True)\n",
    "    second = df['Second Clinical Trial'].reset_index(drop=True)\n",
    "\n",
    "    if num_trials <= 1:\n",
    "        return df\n",
    "\n",
    "    while len(first[~first.isna()]) > 1:\n",
    "        first_nonnull_index = first[~first.isna()].index[-1]\n",
    "        to_move = first.iloc[first_nonnull_index]\n",
    "        first_null_index = second[second.isna()].index[0]\n",
    "        second.iloc[first_null_index] = to_move\n",
    "        first[first_nonnull_index] = np.NaN\n",
    "\n",
    "    df['First Clinical Trial'] = first\n",
    "    df['Second Clinical Trial'] = second\n",
    "    return df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.1</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding our un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Opportunity to develop an immune modulatory ap...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Neoadjuvant Immunoradiotherapy in Head &amp; Neck ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>61.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.2</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Improve outcomes for HNSCC by expanding out un...</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>62.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>6.3</td>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Leverage our administrative, biostatistics, co...</td>\n",
       "      <td>Develop emerging, novel, high quality translat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer immunotherapies have led to major treat...</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>2021-07-01</td>\n",
       "      <td>2022-06-30</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     ID Event Name  Award ID  \\\n",
       "0   6.0    Initial       6.1   \n",
       "1  61.0    Initial       6.2   \n",
       "2  62.0    Initial       6.3   \n",
       "\n",
       "                                       Project Title        PI Institution  \\\n",
       "0  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "1  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "2  UCSD-UCSF Specialized Program of Research Exce...  Moores Cancer Center   \n",
       "\n",
       "  Other Institution  Prevention and diagnostic tools  \\\n",
       "0               NaN                            False   \n",
       "1               NaN                            False   \n",
       "2               NaN                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                       True                          False   \n",
       "2                                       True                          False   \n",
       "\n",
       "   Pediatric cancers        Specific Aims  \\\n",
       "0              False  Three Specific Aims   \n",
       "1              False    Two Specific Aims   \n",
       "2              False    Two Specific Aims   \n",
       "\n",
       "                                               Aim 1  \\\n",
       "0  Improve outcomes for HNSCC by expanding our un...   \n",
       "1  Improve outcomes for HNSCC by expanding out un...   \n",
       "2  Leverage our administrative, biostatistics, co...   \n",
       "\n",
       "                                               Aim 2  \\\n",
       "0  Leverage our administrative, biostatistics, co...   \n",
       "1  Leverage our administrative, biostatistics, co...   \n",
       "2  Develop emerging, novel, high quality translat...   \n",
       "\n",
       "                                               Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0  Develop emerging, novel, high quality translat...   NaN   NaN   NaN   \n",
       "1                                                NaN   NaN   NaN   NaN   \n",
       "2                                                NaN   NaN   NaN   NaN   \n",
       "\n",
       "                          Public Health Significance  Award Amount  \\\n",
       "0  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "1  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "2  Cancer immunotherapies have led to major treat...      200000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2021-07-01      2022-06-30  Complete     False   \n",
       "1        2021-07-01      2022-06-30  Complete     False   \n",
       "2        2021-07-01      2022-06-30  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                  True   \n",
       "1                   False                                  True   \n",
       "2                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                            True   \n",
       "1                   True                            True   \n",
       "2                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                    True                                  False   \n",
       "2                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                    False                True                        True   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                      True                                    False   \n",
       "2                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                False                                  False   \n",
       "2                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                  False                           False   \n",
       "2                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                    False   \n",
       "2                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                 No       \n",
       "2                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  Opportunity to develop an immune modulatory ap...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted                      First Clinical Trial  \\\n",
       "0                       1.0  Metformin for oral cancer prevention 2.0   \n",
       "1                       1.0                                       NaN   \n",
       "2                       0.0                                       NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count  \\\n",
       "0                                80.0   \n",
       "1                                 0.0   \n",
       "2                                 NaN   \n",
       "\n",
       "                               Second Clinical Trial  \\\n",
       "0  Neoadjuvant Immunoradiotherapy in Head & Neck ...   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                  NaN                No            No   \n",
       "1                                  NaN               NaN            No   \n",
       "2                                  NaN               NaN           NaN   \n",
       "\n",
       "  Patent Details Peer-Reviewed Publications Count  \n",
       "0            NaN                              Two  \n",
       "1            NaN                              Two  \n",
       "2            NaN                              NaN  "
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "adjust_cli_trials_names(roi, 'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Irreversible electroporation as an In Situ vaccine for pancreatic cancer\n",
      "Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C\n",
      "Decoding Colon Cancers Using Boolean Principles\n",
      "Targeting cellular mechanotransduction in breast cancer metastasis\n",
      "Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L\n",
      "Identification of therapeutic targets of B-ALL using Boolean logic\n",
      "Developing targeted therapy for Ewing sarcoma metastasis\n",
      "Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse\n",
      "Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)\n",
      "UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer\n",
      "FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma\n",
      "An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target\n",
      "The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies\n",
      "Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies\n",
      "Tissue-specific role of SMARCB1 in pediatric Rhabdoid tumors\n",
      "Understanding and Targeting NRF2 in Pancreatic Cancer\n",
      "Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs\n",
      "Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation\n",
      "Targeting CD114 Signaling in Pediatric Medulloblastoma\n",
      "Knowledge-based planning and treatment decision-making for gynecologic brachytherapy\n",
      "Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling\n",
      "New Therapies for Myeloid Leukemia\n",
      "Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk\n",
      "Precision Interception of Gastric Cancers\n",
      "Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC\n",
      "Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC\n",
      "Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models\n",
      "Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain\n",
      "Epigenetic basis of platinum drug resistance in ovarian cancer\n",
      "A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis\n",
      "A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers\n",
      "Targeting Stem Cell Signals in Cancer Development and Progression\n",
      "Cytotoxic Breast Cancer Treatment Effects on Aging\n",
      "Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer\n",
      "In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy\n",
      "Small molecule screen for inhibitors of the GOLPH3 pathway\n",
      "Applying p38 MAPK inhibitors to tackle breast cancer metastasis\n",
      "Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy\n",
      "Targeting imatinib-resistant, KIT-negative cells in human GISTs\n",
      "Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients\n",
      "Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs\n",
      "Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients \n",
      "KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts\n",
      "Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer\n",
      "Detecting dysregulated genes in neuroblastoma using allele-specific expression\n",
      "Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression\n",
      "Microbe-Associated Colorectal Cancer (M.A.C.S)\n",
      "Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer\n",
      "Natural Killer Cells for Treatment of Medulloblastoma\n",
      "Targeting FZD7 in human cancers\n",
      "Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot\n",
      "Responses of Melanoma Patients to Checkpoint Immunotherapy\n",
      "Functional Roles for Histidine Kinase Signaling in Neuroblastoma\n",
      "Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors\n",
      "Epigenetic profiling of endometrial cancer\n",
      "Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials\n",
      "Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic\n",
      "Novel Pathways Regulated by NME1 in Neuroblastoma\n",
      "A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer\n",
      "An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)\n",
      "A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma\n",
      "Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma\n",
      "Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer\n",
      "A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors\n",
      "Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer\n",
      "Low Dose Chemotherapy for Immuno-activation in Lung Cancer\n",
      "Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures\n",
      "A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer\n",
      "An over-expressed GPCR in pacreatic cancer associated fibroblasts as a novel therapeutic target\n",
      "Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors\n",
      "Transcriptomic and epigenomic profiling to reveal TIL and microglia functional phenotype and clonality in pediatric brain tumors\n",
      "A Phase 1b Safety and Feasibility Study of Personalized  Immunotherapy in Adults with Advanced Cancers\n",
      "Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors\n",
      "Junk2\n",
      "Junk\n",
      "Fake Project to Test\n",
      "Test title\n",
      "Novel kinase inhibitors in combination with retinoic acide for neuroblastoma\n",
      "Science\n"
     ]
    }
   ],
   "source": [
    "for i in roi['Project Title'].value_counts().index:\n",
    "    print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove dummy/test projects\n",
    "\n",
    "roi = roi[~roi['Project Title'].isin(['Junk2', 'Junk', 'Fake Project to Test', 'Test title'])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Discovery of non-coding oncogenic mutations in pediatric acute lymphoblastic leukemia using ATAC-seq and Hi-C',\n",
       "       'Irreversible electroporation as an In Situ vaccine for pancreatic cancer',\n",
       "       'Decoding Colon Cancers Using Boolean Principles',\n",
       "       'Deciphering the role of RNA editing in leukemia stem cell generation and pediatric acute leukemia relapse',\n",
       "       'Identification of therapeutic targets of B-ALL using Boolean logic',\n",
       "       'Developing targeted therapy for Ewing sarcoma metastasis',\n",
       "       'Oncogenic Regulation of B-Lymphomagenesis by the Chromatin Modulator DOT1L',\n",
       "       'Targeting cellular mechanotransduction in breast cancer metastasis',\n",
       "       'Therapeutic Reprogramming of Pancreatic Cancer Stroma Via Modulation of p62 and p53 (YEAR 1)',\n",
       "       'An over-expressed GPCR in pancreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'FEN1 Nuclease-Targeted Therapy for Ewing Sarcoma',\n",
       "       'Identification of genes critical for the production of T cells from human pluripotent stem cells for development of \"off-the-shelf\" T cell immunotherapies',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric Rhabdoid tumors',\n",
       "       'Understanding and Targeting NRF2 in Pancreatic Cancer',\n",
       "       'Highly selective, synthetic, cleavage specificity-based nanobiosensors for tumorigenic and anti-tumorigenic MMPs',\n",
       "       'Targeting CD114 Signaling in Pediatric Medulloblastoma',\n",
       "       'Inhibiting Liver Cancer Stem Cells to Improve Response to Thermal Ablation',\n",
       "       'Knowledge-based planning and treatment decision-making for gynecologic brachytherapy',\n",
       "       'Identification of regulatory programs for glioblastoma cellular hierarchy using single-cell multi-omic profiling',\n",
       "       'The GNAS-PKA Onco-Signaling Network in Colorectal Malignancies',\n",
       "       'UCSD-UCSF Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer',\n",
       "       'Improved Echocardiographic Diagnosis of Anthracycline-Related Cardiac Dysfunction Using Global Longitudinal Strain',\n",
       "       'Epigenetic basis of platinum drug resistance in ovarian cancer',\n",
       "       'New Therapies for Myeloid Leukemia',\n",
       "       'Mechanisms Linking Prolonged Nightly Fasting with Cancer Risk',\n",
       "       'Precision Interception of Gastric Cancers',\n",
       "       'Examination of inhibitors of the ULK1 autophagy kinase as therapeutics in NSCLC',\n",
       "       'Neoantigen-specific T cell responses in exceptional responders to immunotherapy in NSCLC',\n",
       "       'Defining the mechanisms of pancreatic cancer susceptibility in patient-derived organoid models',\n",
       "       'In Vivo Modeling of Anti-Tumor Responses of Human Melanoma Patients and their Responses to Checkpoint Immunotherapy',\n",
       "       'A Novel Role for Histidine Kinase Activity in Neuroblastoma Pathogenesis',\n",
       "       'Detecting Correlates of Vaccine Responses in Allogeneic Hematopoietic Stem Cell Transplant Recipients ',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized Immunotherapy in Adults with Advanced Cancers',\n",
       "       'Protein Kinase C as a Novel Biomarker and Target in Pancreatic Cancer',\n",
       "       'Targeting fibroblast heterogeneity to improve surgical outcomes in pancreatic cancer',\n",
       "       'Cytotoxic Breast Cancer Treatment Effects on Aging',\n",
       "       'Small molecule screen for inhibitors of the GOLPH3 pathway',\n",
       "       'Targeting Stem Cell Signals in Cancer Development and Progression',\n",
       "       'Applying p38 MAPK inhibitors to tackle breast cancer metastasis',\n",
       "       'Stromal reprogramming to enhance the effectiveness of pancreatic cancer therapy',\n",
       "       'Targeting imatinib-resistant, KIT-negative cells in human GISTs',\n",
       "       'Demonstrating the Clinical Utility of Whole Exome Sequencing for Cancer Patients',\n",
       "       'Targeting KRAS mutant lung cancer with biphosphonated/statins and rapamycin analogs',\n",
       "       'KRAS Addiction and Protein Biomarkers of Response to anti-KRAS Therapy in NSCLC Patient Derived Xenografts',\n",
       "       'Detecting dysregulated genes in neuroblastoma using allele-specific expression',\n",
       "       'Investigating the Efficacy of radium-223 with Olaparib in Men with Metastatic Castration-resistant Prostate Cancer',\n",
       "       'Inducing Cytosolic Chromatin Fragments in Cancer Cells to Turn Cold Tumors Hot',\n",
       "       'Enhanced Breast Cancer Risk Prediction from Imputed Gene Expression',\n",
       "       'Novel Pathways Regulated by NME1 in Neuroblastoma',\n",
       "       'Characterization of a GOLPH3 Pathway Inhibitor to Enable a Hit-to-Lead Grant to Develop a Novel Cancer Therapeutic',\n",
       "       'Microbe-Associated Colorectal Cancer (M.A.C.S)',\n",
       "       'Evaluation of carcinogen exposure via genome-wide DNA-adduct signatures',\n",
       "       'Impact of Metformin on Clonal Hematopoiesis and Clinical Outcomes in Breast Cancer',\n",
       "       'Natural Killer Cells for Treatment of Medulloblastoma',\n",
       "       'Targeting FZD7 in human cancers',\n",
       "       'Low Dose Chemotherapy for Immuno-activation in Lung Cancer',\n",
       "       'Responses of Melanoma Patients to Checkpoint Immunotherapy',\n",
       "       'Targeting A Therapeutic Vulnerability in PTEN-Deficient Brain Tumors',\n",
       "       'Elucidating the role of Syk kinase and Syk inhibitors combined with Radiation therapy in Neuroblastoma',\n",
       "       'Epigenetic profiling of endometrial cancer',\n",
       "       'Development and Implementation of a Peer-Navigation Intervention to Improve Research Literacy in Pediatric Cancer Trials',\n",
       "       'Peptide Targeted Delivery of Epigenetic Therapies in Pancreatic Cancer',\n",
       "       'A Phase 1b pilot clinical trial of cirmtuzumab, an anti-ROR1 monoclonal antibody, in combination with paclitaxel for the treatment of patients with metastatic, or locally advanced, unresectable breast cancer',\n",
       "       'An Open-Label, Phase 2 Efficacy Study of Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)',\n",
       "       'A National Phase I Study of Cabozantinib in Combination with 13-cis-Retinoic Acid in Children with Relapsed or Refractory Solid Tumors',\n",
       "       'Functional Roles for Histidine Kinase Signaling in Neuroblastoma',\n",
       "       'A pilot trial to test the benefit of real time drug screening to determine individualized treatment plans for children and young adults with relapsed or refractory medulloblastoma',\n",
       "       'A Phase 1B, Nonrandomized Trial Investigating Docetaxel Combined with Cirmtuzumab in Patients with Metastatic Castration Resistant Prostate Cancer',\n",
       "       'An over-expressed GPCR in pacreatic cancer associated fibroblasts as a novel therapeutic target',\n",
       "       'Tissue-specific role of SMARCB1 in pediatric rhabdoid tumors',\n",
       "       'Transcriptomic and epigenomic profiling to reveal TIL and microglia functional phenotype and clonality in pediatric brain tumors',\n",
       "       'A Phase 1b Safety and Feasibility Study of Personalized  Immunotherapy in Adults with Advanced Cancers',\n",
       "       'Transcriptomic, epigenomic profiling to reveal TIL, microglia functional phenotype, and clonality in pediatric brain tumors',\n",
       "       'Novel kinase inhibitors in combination with retinoic acide for neuroblastoma',\n",
       "       'Science'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 150,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "roi['Project Title'].value_counts().index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>51.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>51.1</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>To determine the functional significance of AD...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Pedal the cause helped us to recruit five facu...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Ruxolitinib with or without navitoxlax (Abbvie)</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Ruxolitinib with or without BET inhibitors (CPI)</td>\n",
       "      <td>2.0</td>\n",
       "      <td>Aspera Biomedicines</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Please see justia patents:  https://patents.ju...</td>\n",
       "      <td>More than Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>130.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>51.2</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>To determine the functional significance of AD...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>198.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>198.1</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Deciphering the Role of RNA Editing in Leukemi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>199.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>198.2</td>\n",
       "      <td>Deciphering the role of RNA editing in leukemi...</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>One Specific Aim</td>\n",
       "      <td>Deciphering the Role of RNA Editing in Leukemi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute lymphoblastic leukemia (ALL) is the comm...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      ID Event Name  Award ID  \\\n",
       "0   51.0    Initial      51.1   \n",
       "1  130.0    Initial      51.2   \n",
       "2  198.0    Initial     198.1   \n",
       "3  199.0    Initial     198.2   \n",
       "\n",
       "                                       Project Title  \\\n",
       "0  Deciphering the role of RNA editing in leukemi...   \n",
       "1  Deciphering the role of RNA editing in leukemi...   \n",
       "2  Deciphering the role of RNA editing in leukemi...   \n",
       "3  Deciphering the role of RNA editing in leukemi...   \n",
       "\n",
       "                                PI Institution Other Institution  \\\n",
       "0                         Moores Cancer Center               NaN   \n",
       "1                              Rady Children's               NaN   \n",
       "2                              Rady Children's               NaN   \n",
       "3  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "   Prevention and diagnostic tools  \\\n",
       "0                            False   \n",
       "1                            False   \n",
       "2                            False   \n",
       "3                            False   \n",
       "\n",
       "   Novel approaches and new therapeutic platforms  \\\n",
       "0                                           False   \n",
       "1                                           False   \n",
       "2                                           False   \n",
       "3                                           False   \n",
       "\n",
       "   Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                      False                          False   \n",
       "1                                      False                          False   \n",
       "2                                      False                          False   \n",
       "3                                      False                          False   \n",
       "\n",
       "   Pediatric cancers     Specific Aims  \\\n",
       "0               True  One Specific Aim   \n",
       "1               True  One Specific Aim   \n",
       "2               True  One Specific Aim   \n",
       "3               True  One Specific Aim   \n",
       "\n",
       "                                               Aim 1 Aim 2 Aim 3 Aim 4 Aim 5  \\\n",
       "0  To determine the functional significance of AD...   NaN   NaN   NaN   NaN   \n",
       "1  To determine the functional significance of AD...   NaN   NaN   NaN   NaN   \n",
       "2  Deciphering the Role of RNA Editing in Leukemi...   NaN   NaN   NaN   NaN   \n",
       "3  Deciphering the Role of RNA Editing in Leukemi...   NaN   NaN   NaN   NaN   \n",
       "\n",
       "  Aim 6                         Public Health Significance  Award Amount  \\\n",
       "0   NaN  Acute lymphoblastic leukemia (ALL) is the comm...       75000.0   \n",
       "1   NaN  Acute lymphoblastic leukemia (ALL) is the comm...       75000.0   \n",
       "2   NaN  Acute lymphoblastic leukemia (ALL) is the comm...       75000.0   \n",
       "3   NaN  Acute lymphoblastic leukemia (ALL) is the comm...       75000.0   \n",
       "\n",
       "  Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "0        2017-06-01      2018-05-31  Complete     False   \n",
       "1        2017-06-01      2018-05-31  Complete       NaN   \n",
       "2        2017-06-01      2018-05-31  Complete       NaN   \n",
       "3        2017-06-01      2018-05-31  Complete       NaN   \n",
       "\n",
       "  SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                   False                                  True   \n",
       "1                     NaN                                   NaN   \n",
       "2                     NaN                                   NaN   \n",
       "3                     NaN                                   NaN   \n",
       "\n",
       "  SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                  False                            True   \n",
       "1                    NaN                             NaN   \n",
       "2                    NaN                             NaN   \n",
       "3                    NaN                             NaN   \n",
       "\n",
       "  SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                   False                                   True   \n",
       "1                     NaN                                    NaN   \n",
       "2                     NaN                                    NaN   \n",
       "3                     NaN                                    NaN   \n",
       "\n",
       "  SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                    False               False                       False   \n",
       "1                      NaN                 NaN                         NaN   \n",
       "2                      NaN                 NaN                         NaN   \n",
       "3                      NaN                 NaN                         NaN   \n",
       "\n",
       "  SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                     False                                    False   \n",
       "1                       NaN                                      NaN   \n",
       "2                       NaN                                      NaN   \n",
       "3                       NaN                                      NaN   \n",
       "\n",
       "  SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                False                                  False   \n",
       "1                  NaN                                    NaN   \n",
       "2                  NaN                                    NaN   \n",
       "3                  NaN                                    NaN   \n",
       "\n",
       "  SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                  False                           False   \n",
       "1                                    NaN                             NaN   \n",
       "2                                    NaN                             NaN   \n",
       "3                                    NaN                             NaN   \n",
       "\n",
       "  Cancer Metabolism SBPMDI  \\\n",
       "0                    False   \n",
       "1                      NaN   \n",
       "2                      NaN   \n",
       "3                      NaN   \n",
       "\n",
       "  Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                Yes       \n",
       "1                                                NaN       \n",
       "2                                                NaN       \n",
       "3                                                NaN       \n",
       "\n",
       "                              If yes, please specify If no, please specify  \\\n",
       "0  Pedal the cause helped us to recruit five facu...                   NaN   \n",
       "1                                                NaN                   NaN   \n",
       "2                                                NaN                   NaN   \n",
       "3                                                NaN                   NaN   \n",
       "\n",
       "   Clinical Trials Resulted                             First Clinical Trial  \\\n",
       "0                       2.0  Ruxolitinib with or without navitoxlax (Abbvie)   \n",
       "1                       0.0                                              NaN   \n",
       "2                       0.0                                              NaN   \n",
       "3                       0.0                                              NaN   \n",
       "\n",
       "   First Clinical Trial Patient Count  \\\n",
       "0                                 2.0   \n",
       "1                                 NaN   \n",
       "2                                 NaN   \n",
       "3                                 NaN   \n",
       "\n",
       "                              Second Clinical Trial  \\\n",
       "0  Ruxolitinib with or without BET inhibitors (CPI)   \n",
       "1                                               NaN   \n",
       "2                                               NaN   \n",
       "3                                               NaN   \n",
       "\n",
       "   Second Clinical Trial Patient Count    Companies Founded Patents Filed  \\\n",
       "0                                  2.0  Aspera Biomedicines           Yes   \n",
       "1                                  NaN                  NaN           NaN   \n",
       "2                                  NaN                  NaN           NaN   \n",
       "3                                  NaN                  NaN           NaN   \n",
       "\n",
       "                                      Patent Details  \\\n",
       "0  Please see justia patents:  https://patents.ju...   \n",
       "1                                                NaN   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "\n",
       "  Peer-Reviewed Publications Count  \n",
       "0                    More than Ten  \n",
       "1                              NaN  \n",
       "2                              NaN  \n",
       "3                              NaN  "
      ]
     },
     "execution_count": 151,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Apply clinical trial names adjustment function to all projects\n",
    "\n",
    "projs = roi['Project Title'].value_counts().index\n",
    "proj_data = []\n",
    "for p in projs:\n",
    "    df = adjust_cli_trials_names(roi, p)\n",
    "    proj_data.append(df)\n",
    "proj_data[3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>52.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funding for this project and the data gene...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>131.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Obtaining funding is important for career adva...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>52.3</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding for this project enhanced innovative c...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>200.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.1</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>201.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>200.2</td>\n",
       "      <td>Discovery of non-coding oncogenic mutations in...</td>\n",
       "      <td>Salk Institute</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Discover non-coding regulatory mutations in AL...</td>\n",
       "      <td>Discover large-scale structural mutations and ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Acute Lymphoblastic Leukemia (ALL) is the most...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>38.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>38.1</td>\n",
       "      <td>Transcriptomic and epigenomic profiling to rev...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-infiltrating CD4+ T cell, CD8+ T cell an...</td>\n",
       "      <td>Tumor-associated microglia and other key immun...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brain tumors are a leading cause of death amon...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>During my hematology oncology fellowship, I un...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>39.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>39.1</td>\n",
       "      <td>A Phase 1b Safety and Feasibility Study of Per...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Conduct a phase 1b clinical trial to assess do...</td>\n",
       "      <td>Characterize the vaccine contribution to T cel...</td>\n",
       "      <td>Determine the extent of epitope spreading seco...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Immunotherapy has produced a paradigm shift in...</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2019-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The funds were critical in advancing the caree...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NCT05153304  Protocol PCV-001  A Phase I/II Sa...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, Lykeion</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Patent filed for the neoantigen discovery and ...</td>\n",
       "      <td>Six - Ten</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>113.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>38.2</td>\n",
       "      <td>Transcriptomic, epigenomic profiling to reveal...</td>\n",
       "      <td>LJI</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Tumor-infiltrating CD4+ T cell, CD8+ T cell an...</td>\n",
       "      <td>Tumor-associated microglia and other key immun...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Brain tumors are a leading cause of death amon...</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>2018-06-01</td>\n",
       "      <td>2019-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The Pedal The Cause funding was an important f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Two</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>55.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>55.1</td>\n",
       "      <td>Novel kinase inhibitors in combination with re...</td>\n",
       "      <td>Rady Children's</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>Two Specific Aims</td>\n",
       "      <td>Determine the efficacy of CRA treatment combin...</td>\n",
       "      <td>Evaluate the functional role of the RAS-MAPK p...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Children with aggressive neuroblastoma have po...</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2017-06-01</td>\n",
       "      <td>2018-05-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The availability of funding from Padres Pedal ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>none</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>207.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Science</td>\n",
       "      <td>UCSD - not a member of Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>science project</td>\n",
       "      <td>Health Project</td>\n",
       "      <td>Both</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>diana</td>\n",
       "      <td>75000.0</td>\n",
       "      <td>2022-08-01</td>\n",
       "      <td>2022-08-31</td>\n",
       "      <td>Incomplete</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>186 rows × 52 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "0     52.0    Initial      52.1   \n",
       "1    131.0    Initial      52.2   \n",
       "2    132.0    Initial      52.3   \n",
       "3    200.0    Initial     200.1   \n",
       "4    201.0    Initial     200.2   \n",
       "..     ...        ...       ...   \n",
       "181   38.0    Initial      38.1   \n",
       "182   39.0    Initial      39.1   \n",
       "183  113.0    Initial      38.2   \n",
       "184   55.0    Initial      55.1   \n",
       "185  207.0    Initial       NaN   \n",
       "\n",
       "                                         Project Title  \\\n",
       "0    Discovery of non-coding oncogenic mutations in...   \n",
       "1    Discovery of non-coding oncogenic mutations in...   \n",
       "2    Discovery of non-coding oncogenic mutations in...   \n",
       "3    Discovery of non-coding oncogenic mutations in...   \n",
       "4    Discovery of non-coding oncogenic mutations in...   \n",
       "..                                                 ...   \n",
       "181  Transcriptomic and epigenomic profiling to rev...   \n",
       "182  A Phase 1b Safety and Feasibility Study of Per...   \n",
       "183  Transcriptomic, epigenomic profiling to reveal...   \n",
       "184  Novel kinase inhibitors in combination with re...   \n",
       "185                                            Science   \n",
       "\n",
       "                                  PI Institution Other Institution  \\\n",
       "0                                 Salk Institute               NaN   \n",
       "1                                 Salk Institute               NaN   \n",
       "2                                Rady Children's               NaN   \n",
       "3                                 Salk Institute               NaN   \n",
       "4                                 Salk Institute               NaN   \n",
       "..                                           ...               ...   \n",
       "181                              Rady Children's               NaN   \n",
       "182                         Moores Cancer Center               NaN   \n",
       "183                                          LJI               NaN   \n",
       "184                              Rady Children's               NaN   \n",
       "185  UCSD - not a member of Moores Cancer Center               NaN   \n",
       "\n",
       "     Prevention and diagnostic tools  \\\n",
       "0                              False   \n",
       "1                              False   \n",
       "2                              False   \n",
       "3                              False   \n",
       "4                              False   \n",
       "..                               ...   \n",
       "181                            False   \n",
       "182                            False   \n",
       "183                            False   \n",
       "184                            False   \n",
       "185                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "0                                             False   \n",
       "1                                             False   \n",
       "2                                             False   \n",
       "3                                             False   \n",
       "4                                             False   \n",
       "..                                              ...   \n",
       "181                                           False   \n",
       "182                                           False   \n",
       "183                                           False   \n",
       "184                                           False   \n",
       "185                                           False   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "0                                        False                          False   \n",
       "1                                        False                          False   \n",
       "2                                        False                          False   \n",
       "3                                        False                          False   \n",
       "4                                        False                          False   \n",
       "..                                         ...                            ...   \n",
       "181                                       True                          False   \n",
       "182                                       True                          False   \n",
       "183                                       True                          False   \n",
       "184                                      False                          False   \n",
       "185                                      False                           True   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "0                 True    Two Specific Aims   \n",
       "1                 True    Two Specific Aims   \n",
       "2                 True    Two Specific Aims   \n",
       "3                 True    Two Specific Aims   \n",
       "4                 True    Two Specific Aims   \n",
       "..                 ...                  ...   \n",
       "181              False    Two Specific Aims   \n",
       "182              False  Three Specific Aims   \n",
       "183              False    Two Specific Aims   \n",
       "184               True    Two Specific Aims   \n",
       "185              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "0    Discover non-coding regulatory mutations in AL...   \n",
       "1    Discover non-coding regulatory mutations in AL...   \n",
       "2    Discover non-coding regulatory mutations in AL...   \n",
       "3    Discover non-coding regulatory mutations in AL...   \n",
       "4    Discover non-coding regulatory mutations in AL...   \n",
       "..                                                 ...   \n",
       "181  Tumor-infiltrating CD4+ T cell, CD8+ T cell an...   \n",
       "182  Conduct a phase 1b clinical trial to assess do...   \n",
       "183  Tumor-infiltrating CD4+ T cell, CD8+ T cell an...   \n",
       "184  Determine the efficacy of CRA treatment combin...   \n",
       "185                                    science project   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "0    Discover large-scale structural mutations and ...   \n",
       "1    Discover large-scale structural mutations and ...   \n",
       "2    Discover large-scale structural mutations and ...   \n",
       "3    Discover large-scale structural mutations and ...   \n",
       "4    Discover large-scale structural mutations and ...   \n",
       "..                                                 ...   \n",
       "181  Tumor-associated microglia and other key immun...   \n",
       "182  Characterize the vaccine contribution to T cel...   \n",
       "183  Tumor-associated microglia and other key immun...   \n",
       "184  Evaluate the functional role of the RAS-MAPK p...   \n",
       "185                                     Health Project   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "0                                                  NaN   NaN   NaN   NaN   \n",
       "1                                                  NaN   NaN   NaN   NaN   \n",
       "2                                                  NaN   NaN   NaN   NaN   \n",
       "3                                                  NaN   NaN   NaN   NaN   \n",
       "4                                                  NaN   NaN   NaN   NaN   \n",
       "..                                                 ...   ...   ...   ...   \n",
       "181                                                NaN   NaN   NaN   NaN   \n",
       "182  Determine the extent of epitope spreading seco...   NaN   NaN   NaN   \n",
       "183                                                NaN   NaN   NaN   NaN   \n",
       "184                                                NaN   NaN   NaN   NaN   \n",
       "185                                               Both   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "0    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "1    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "2    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "3    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "4    Acute Lymphoblastic Leukemia (ALL) is the most...       75000.0   \n",
       "..                                                 ...           ...   \n",
       "181  Brain tumors are a leading cause of death amon...      100000.0   \n",
       "182  Immunotherapy has produced a paradigm shift in...      150000.0   \n",
       "183  Brain tumors are a leading cause of death amon...      100000.0   \n",
       "184  Children with aggressive neuroblastoma have po...       75000.0   \n",
       "185                                              diana       75000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:    Complete SR - None  \\\n",
       "0          2017-06-01      2018-05-31    Complete      True   \n",
       "1          2017-06-01      2018-05-31    Complete      True   \n",
       "2          2017-06-01      2018-05-31    Complete      True   \n",
       "3          2017-06-01      2018-05-31    Complete       NaN   \n",
       "4          2017-06-01      2018-05-31    Complete       NaN   \n",
       "..                ...             ...         ...       ...   \n",
       "181        2018-06-01      2019-05-31    Complete      True   \n",
       "182        2019-01-01      2019-12-31    Complete     False   \n",
       "183        2018-06-01      2019-05-31    Complete      True   \n",
       "184        2017-06-01      2018-05-31    Complete     False   \n",
       "185        2022-08-01      2022-08-31  Incomplete       NaN   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "0                     False                                 False   \n",
       "1                     False                                 False   \n",
       "2                     False                                 False   \n",
       "3                       NaN                                   NaN   \n",
       "4                       NaN                                   NaN   \n",
       "..                      ...                                   ...   \n",
       "181                   False                                 False   \n",
       "182                   False                                  True   \n",
       "183                   False                                 False   \n",
       "184                   False                                  True   \n",
       "185                     NaN                                   NaN   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "0                    False                           False   \n",
       "1                    False                           False   \n",
       "2                    False                           False   \n",
       "3                      NaN                             NaN   \n",
       "4                      NaN                             NaN   \n",
       "..                     ...                             ...   \n",
       "181                  False                           False   \n",
       "182                   True                            True   \n",
       "183                  False                           False   \n",
       "184                   True                           False   \n",
       "185                    NaN                             NaN   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "0                     False                                  False   \n",
       "1                     False                                  False   \n",
       "2                     False                                  False   \n",
       "3                       NaN                                    NaN   \n",
       "4                       NaN                                    NaN   \n",
       "..                      ...                                    ...   \n",
       "181                   False                                  False   \n",
       "182                   False                                  False   \n",
       "183                   False                                  False   \n",
       "184                   False                                  False   \n",
       "185                     NaN                                    NaN   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "0                      False               False                       False   \n",
       "1                      False               False                       False   \n",
       "2                      False               False                       False   \n",
       "3                        NaN                 NaN                         NaN   \n",
       "4                        NaN                 NaN                         NaN   \n",
       "..                       ...                 ...                         ...   \n",
       "181                    False               False                       False   \n",
       "182                    False               False                       False   \n",
       "183                    False               False                       False   \n",
       "184                     True               False                       False   \n",
       "185                      NaN                 NaN                         NaN   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "0                       False                                    False   \n",
       "1                       False                                    False   \n",
       "2                       False                                    False   \n",
       "3                         NaN                                      NaN   \n",
       "4                         NaN                                      NaN   \n",
       "..                        ...                                      ...   \n",
       "181                     False                                    False   \n",
       "182                     False                                    False   \n",
       "183                     False                                    False   \n",
       "184                     False                                    False   \n",
       "185                       NaN                                      NaN   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "0                  False                                  False   \n",
       "1                  False                                  False   \n",
       "2                  False                                  False   \n",
       "3                    NaN                                    NaN   \n",
       "4                    NaN                                    NaN   \n",
       "..                   ...                                    ...   \n",
       "181                False                                  False   \n",
       "182                False                                  False   \n",
       "183                False                                  False   \n",
       "184                False                                  False   \n",
       "185                  NaN                                    NaN   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "0                                    False                           False   \n",
       "1                                    False                           False   \n",
       "2                                    False                           False   \n",
       "3                                      NaN                             NaN   \n",
       "4                                      NaN                             NaN   \n",
       "..                                     ...                             ...   \n",
       "181                                  False                           False   \n",
       "182                                  False                           False   \n",
       "183                                  False                           False   \n",
       "184                                  False                           False   \n",
       "185                                    NaN                             NaN   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                        NaN   \n",
       "4                        NaN   \n",
       "..                       ...   \n",
       "181                    False   \n",
       "182                    False   \n",
       "183                    False   \n",
       "184                    False   \n",
       "185                      NaN   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "0                                                  Yes       \n",
       "1                                                  Yes       \n",
       "2                                                  Yes       \n",
       "3                                                  NaN       \n",
       "4                                                  NaN       \n",
       "..                                                 ...       \n",
       "181                                                Yes       \n",
       "182                                                Yes       \n",
       "183                                                Yes       \n",
       "184                                                Yes       \n",
       "185                                                NaN       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "0    The funding for this project and the data gene...                   NaN   \n",
       "1    Obtaining funding is important for career adva...                   NaN   \n",
       "2    Funding for this project enhanced innovative c...                   NaN   \n",
       "3                                                  NaN                   NaN   \n",
       "4                                                  NaN                   NaN   \n",
       "..                                                 ...                   ...   \n",
       "181  During my hematology oncology fellowship, I un...                   NaN   \n",
       "182  The funds were critical in advancing the caree...                   NaN   \n",
       "183  The Pedal The Cause funding was an important f...                   NaN   \n",
       "184  The availability of funding from Padres Pedal ...                   NaN   \n",
       "185                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "0                         0.0   \n",
       "1                         0.0   \n",
       "2                         0.0   \n",
       "3                         0.0   \n",
       "4                         0.0   \n",
       "..                        ...   \n",
       "181                       0.0   \n",
       "182                       1.0   \n",
       "183                       0.0   \n",
       "184                       1.0   \n",
       "185                       0.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "..                                                 ...   \n",
       "181                                                NaN   \n",
       "182  NCT05153304  Protocol PCV-001  A Phase I/II Sa...   \n",
       "183                                                NaN   \n",
       "184  A National Phase I Study of Cabozantinib in Co...   \n",
       "185                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count Second Clinical Trial  \\\n",
       "0                                   NaN                   NaN   \n",
       "1                                   NaN                   NaN   \n",
       "2                                   NaN                   NaN   \n",
       "3                                   NaN                   NaN   \n",
       "4                                   NaN                   NaN   \n",
       "..                                  ...                   ...   \n",
       "181                                 NaN                   NaN   \n",
       "182                                 2.0                   NaN   \n",
       "183                                 NaN                   NaN   \n",
       "184                                 6.0                   NaN   \n",
       "185                                 NaN                   NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "0                                    NaN              None            No   \n",
       "1                                    NaN              None            No   \n",
       "2                                    NaN              None            No   \n",
       "3                                    NaN               NaN           NaN   \n",
       "4                                    NaN               NaN           NaN   \n",
       "..                                   ...               ...           ...   \n",
       "181                                  NaN              None            No   \n",
       "182                                  NaN      Yes, Lykeion           Yes   \n",
       "183                                  NaN              None            No   \n",
       "184                                  NaN              none            No   \n",
       "185                                  NaN               NaN           NaN   \n",
       "\n",
       "                                        Patent Details  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3                                                  NaN   \n",
       "4                                                  NaN   \n",
       "..                                                 ...   \n",
       "181                                                NaN   \n",
       "182  Patent filed for the neoantigen discovery and ...   \n",
       "183                                                NaN   \n",
       "184                                                NaN   \n",
       "185                                                NaN   \n",
       "\n",
       "    Peer-Reviewed Publications Count  \n",
       "0                                Two  \n",
       "1                                One  \n",
       "2                                Two  \n",
       "3                                NaN  \n",
       "4                                NaN  \n",
       "..                               ...  \n",
       "181                              Two  \n",
       "182                        Six - Ten  \n",
       "183                              Two  \n",
       "184                            Three  \n",
       "185                              NaN  \n",
       "\n",
       "[186 rows x 52 columns]"
      ]
     },
     "execution_count": 153,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Concatenate adjusted dataframes into one\n",
    "\n",
    "roi_adj = pd.concat(proj_data, ignore_index=True)\n",
    "roi_adj"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Award ID</th>\n",
       "      <th>Project Title</th>\n",
       "      <th>PI Institution</th>\n",
       "      <th>Other Institution</th>\n",
       "      <th>Prevention and diagnostic tools</th>\n",
       "      <th>Novel approaches and new therapeutic platforms</th>\n",
       "      <th>Immunotherapies and personalized vaccines</th>\n",
       "      <th>Addressing cancer disparities</th>\n",
       "      <th>Pediatric cancers</th>\n",
       "      <th>Specific Aims</th>\n",
       "      <th>Aim 1</th>\n",
       "      <th>Aim 2</th>\n",
       "      <th>Aim 3</th>\n",
       "      <th>Aim 4</th>\n",
       "      <th>Aim 5</th>\n",
       "      <th>Aim 6</th>\n",
       "      <th>Public Health Significance</th>\n",
       "      <th>Award Amount</th>\n",
       "      <th>Grant Start Date:</th>\n",
       "      <th>Grant End Date:</th>\n",
       "      <th>Complete</th>\n",
       "      <th>SR - None</th>\n",
       "      <th>SR - Biobehaviorial MCC</th>\n",
       "      <th>SR - Biorepository &amp; Tissue Tech. MCC</th>\n",
       "      <th>SR - Biostatistics MCC</th>\n",
       "      <th>SR - Clinical Trials Office MCC</th>\n",
       "      <th>SR - Flow Cytometry MCC</th>\n",
       "      <th>SR - Genomics &amp; Computational Bio. MCC</th>\n",
       "      <th>SR - In Vivo Imaging MCC</th>\n",
       "      <th>SR - Microscopy MCC</th>\n",
       "      <th>SR - Radiation Medicine MCC</th>\n",
       "      <th>SR - Transgenic Mouse MCC</th>\n",
       "      <th>SR - Gene Transfer/Targeting/Therap Salk</th>\n",
       "      <th>SR - Transgenic Salk</th>\n",
       "      <th>SR - Mass Spect - Proteom/Metabol Salk</th>\n",
       "      <th>SR - Chemical Library Screening SBPMDI</th>\n",
       "      <th>SR - Functional Genomics SBPMDI</th>\n",
       "      <th>Cancer Metabolism SBPMDI</th>\n",
       "      <th>Pedal Importance (recruitment, retention, advancement)</th>\n",
       "      <th>If yes, please specify</th>\n",
       "      <th>If no, please specify</th>\n",
       "      <th>Clinical Trials Resulted</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>First Clinical Trial Patient Count</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "      <th>Second Clinical Trial Patient Count</th>\n",
       "      <th>Companies Founded</th>\n",
       "      <th>Patents Filed</th>\n",
       "      <th>Patent Details</th>\n",
       "      <th>Peer-Reviewed Publications Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>41.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.1</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Yes</td>\n",
       "      <td>The PTC funding lead to preliminary data for a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>Trial Name:    Temozolomide (TMZ) In Advanced ...</td>\n",
       "      <td>13.0</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Three</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>118.0</td>\n",
       "      <td>Initial</td>\n",
       "      <td>41.2</td>\n",
       "      <td>An Open-Label, Phase 2 Efficacy Study of Temoz...</td>\n",
       "      <td>Moores Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>Three Specific Aims</td>\n",
       "      <td>Primary objective: To determine overall respon...</td>\n",
       "      <td>Secondary objective: To determine progression-...</td>\n",
       "      <td>Exploratory objective: To investigate serum me...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Gastrointestinal stromal tumor (GIST) caused b...</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>2020-12-31</td>\n",
       "      <td>Complete</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID Event Name  Award ID  \\\n",
       "170   41.0    Initial      41.1   \n",
       "171  118.0    Initial      41.2   \n",
       "\n",
       "                                         Project Title        PI Institution  \\\n",
       "170  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "171  An Open-Label, Phase 2 Efficacy Study of Temoz...  Moores Cancer Center   \n",
       "\n",
       "    Other Institution  Prevention and diagnostic tools  \\\n",
       "170               NaN                            False   \n",
       "171               NaN                            False   \n",
       "\n",
       "     Novel approaches and new therapeutic platforms  \\\n",
       "170                                            True   \n",
       "171                                            True   \n",
       "\n",
       "     Immunotherapies and personalized vaccines  Addressing cancer disparities  \\\n",
       "170                                      False                          False   \n",
       "171                                      False                          False   \n",
       "\n",
       "     Pediatric cancers        Specific Aims  \\\n",
       "170              False  Three Specific Aims   \n",
       "171              False  Three Specific Aims   \n",
       "\n",
       "                                                 Aim 1  \\\n",
       "170  Primary objective: To determine overall respon...   \n",
       "171  Primary objective: To determine overall respon...   \n",
       "\n",
       "                                                 Aim 2  \\\n",
       "170  Secondary objective: To determine progression-...   \n",
       "171  Secondary objective: To determine progression-...   \n",
       "\n",
       "                                                 Aim 3 Aim 4 Aim 5 Aim 6  \\\n",
       "170  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "171  Exploratory objective: To investigate serum me...   NaN   NaN   NaN   \n",
       "\n",
       "                            Public Health Significance  Award Amount  \\\n",
       "170  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "171  Gastrointestinal stromal tumor (GIST) caused b...      300000.0   \n",
       "\n",
       "    Grant Start Date: Grant End Date:  Complete SR - None  \\\n",
       "170        2019-01-01      2020-12-31  Complete     False   \n",
       "171        2019-01-01      2020-12-31  Complete     False   \n",
       "\n",
       "    SR - Biobehaviorial MCC SR - Biorepository & Tissue Tech. MCC  \\\n",
       "170                   False                                  True   \n",
       "171                   False                                  True   \n",
       "\n",
       "    SR - Biostatistics MCC SR - Clinical Trials Office MCC  \\\n",
       "170                   True                            True   \n",
       "171                   True                            True   \n",
       "\n",
       "    SR - Flow Cytometry MCC SR - Genomics & Computational Bio. MCC  \\\n",
       "170                   False                                  False   \n",
       "171                   False                                  False   \n",
       "\n",
       "    SR - In Vivo Imaging MCC SR - Microscopy MCC SR - Radiation Medicine MCC  \\\n",
       "170                    False               False                       False   \n",
       "171                    False               False                       False   \n",
       "\n",
       "    SR - Transgenic Mouse MCC SR - Gene Transfer/Targeting/Therap Salk  \\\n",
       "170                     False                                    False   \n",
       "171                     False                                    False   \n",
       "\n",
       "    SR - Transgenic Salk SR - Mass Spect - Proteom/Metabol Salk  \\\n",
       "170                False                                  False   \n",
       "171                False                                  False   \n",
       "\n",
       "    SR - Chemical Library Screening SBPMDI SR - Functional Genomics SBPMDI  \\\n",
       "170                                  False                           False   \n",
       "171                                  False                           False   \n",
       "\n",
       "    Cancer Metabolism SBPMDI  \\\n",
       "170                    False   \n",
       "171                    False   \n",
       "\n",
       "    Pedal Importance (recruitment, retention, advancement)  \\\n",
       "170                                                Yes       \n",
       "171                                                 No       \n",
       "\n",
       "                                If yes, please specify If no, please specify  \\\n",
       "170  The PTC funding lead to preliminary data for a...                   NaN   \n",
       "171                                                NaN                   NaN   \n",
       "\n",
       "     Clinical Trials Resulted  \\\n",
       "170                       1.0   \n",
       "171                       1.0   \n",
       "\n",
       "                                  First Clinical Trial  \\\n",
       "170  Trial Name:    Temozolomide (TMZ) In Advanced ...   \n",
       "171                                                NaN   \n",
       "\n",
       "     First Clinical Trial Patient Count  \\\n",
       "170                                13.0   \n",
       "171                                18.0   \n",
       "\n",
       "                                 Second Clinical Trial  \\\n",
       "170  An Open-Label, Phase 2 Efficacy Study of Temoz...   \n",
       "171                                                NaN   \n",
       "\n",
       "     Second Clinical Trial Patient Count Companies Founded Patents Filed  \\\n",
       "170                                  NaN              None            No   \n",
       "171                                  NaN               NaN            No   \n",
       "\n",
       "    Patent Details Peer-Reviewed Publications Count  \n",
       "170            NaN                            Three  \n",
       "171            NaN                              One  "
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sanity checks\n",
    "\n",
    "roi_adj.loc[\n",
    "    roi_adj['Project Title'].apply(lambda x: True if re.match(r'^An Open-Label', x) else False), :\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Project Title</th>\n",
       "      <th>First Clinical Trial</th>\n",
       "      <th>Second Clinical Trial</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>Understanding and Targeting NRF2 in Pancreatic...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>Metformin for oral cancer prevention 2.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>UCSD-UCSF Specialized Program of Research Exce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>A Phase 1B, Nonrandomized Trial Investigating ...</td>\n",
       "      <td>Phase 1B, Nonrandomized Trial Investigating Do...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>A Novel Role for Histidine Kinase Activity in ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>A National Phase I Study of Cabozantinib in Co...</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>190 rows × 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                         Project Title  \\\n",
       "57   Understanding and Targeting NRF2 in Pancreatic...   \n",
       "169  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "171  Understanding and Targeting NRF2 in Pancreatic...   \n",
       "6    UCSD-UCSF Specialized Program of Research Exce...   \n",
       "105  UCSD-UCSF Specialized Program of Research Exce...   \n",
       "..                                                 ...   \n",
       "8    A Phase 1B, Nonrandomized Trial Investigating ...   \n",
       "222  A Novel Role for Histidine Kinase Activity in ...   \n",
       "224  A Novel Role for Histidine Kinase Activity in ...   \n",
       "102  A National Phase I Study of Cabozantinib in Co...   \n",
       "4    A National Phase I Study of Cabozantinib in Co...   \n",
       "\n",
       "                                  First Clinical Trial Second Clinical Trial  \n",
       "57                                                 NaN                   NaN  \n",
       "169                                                NaN                   NaN  \n",
       "171                                                NaN                   NaN  \n",
       "6             Metformin for oral cancer prevention 2.0                   NaN  \n",
       "105                                                NaN                   NaN  \n",
       "..                                                 ...                   ...  \n",
       "8    Phase 1B, Nonrandomized Trial Investigating Do...                   NaN  \n",
       "222                                                NaN                   NaN  \n",
       "224                                                NaN                   NaN  \n",
       "102                                                NaN                   NaN  \n",
       "4    A National Phase I Study of Cabozantinib in Co...                   NaN  \n",
       "\n",
       "[190 rows x 3 columns]"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.set_option('display.max_rows', 22)\n",
    "roi[['Project Title', 'First Clinical Trial', 'Second Clinical Trial']].sort_values(by='Project Title', ascending=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Save cleaned dataframes to csv files in interim\n",
    "# Caution: examine directory before uncomment/run this cell to prevent duplicate\n",
    "# files or unintentional modifications to files\n",
    "\n",
    "wp = os.path.join('interim', 'tableau-datasets', '2022_Pedal_ROI.csv')\n",
    "roi_adj.to_csv(wp)\n",
    "\n",
    "# wp = os.path.join('interim', '2022_Pedal_Progress_Report.csv')\n",
    "# prog_r.to_csv(wp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Event Name</th>\n",
       "      <th>Publication Status 4</th>\n",
       "      <th>Fourth DOI #</th>\n",
       "      <th>Publication Status 5</th>\n",
       "      <th>Fifth DOI #</th>\n",
       "      <th>Publication Status 6</th>\n",
       "      <th>Sixth DOI #</th>\n",
       "      <th>Publication Status 7</th>\n",
       "      <th>Seventh DOI #</th>\n",
       "      <th>Publication Status 8</th>\n",
       "      <th>Eighth DOI #</th>\n",
       "      <th>Publication Status 9</th>\n",
       "      <th>Ninth DOI #</th>\n",
       "      <th>Publication Status 10</th>\n",
       "      <th>Tenth DOI #</th>\n",
       "      <th>Pedal Non-Peer Pubs</th>\n",
       "      <th>Other Accomplishments</th>\n",
       "      <th>Health Benefits</th>\n",
       "      <th>International</th>\n",
       "      <th>National</th>\n",
       "      <th>Local</th>\n",
       "      <th>General Public</th>\n",
       "      <th>Healthcare Professionals</th>\n",
       "      <th>Patients</th>\n",
       "      <th>Patient Families</th>\n",
       "      <th>Policy Influence</th>\n",
       "      <th>International (pol)</th>\n",
       "      <th>National (pol)</th>\n",
       "      <th>Local (pol)</th>\n",
       "      <th>General Public (pol)</th>\n",
       "      <th>Healthcare Professionals (pol)</th>\n",
       "      <th>Patients (pol)</th>\n",
       "      <th>Patient Families (pol)</th>\n",
       "      <th>Policy Benefits Description</th>\n",
       "      <th>Economic Benefits</th>\n",
       "      <th>International (econ)</th>\n",
       "      <th>National (econ)</th>\n",
       "      <th>Local (econ)</th>\n",
       "      <th>General Public (econ)</th>\n",
       "      <th>Healthcare Professionals (econ)</th>\n",
       "      <th>Patients (econ)</th>\n",
       "      <th>Patient Families (econ)</th>\n",
       "      <th>Economic Benefits Description</th>\n",
       "      <th>Equity Benefits</th>\n",
       "      <th>International (equity)</th>\n",
       "      <th>National (equity)</th>\n",
       "      <th>Local (equity)</th>\n",
       "      <th>General Public (equity)</th>\n",
       "      <th>Healthcare Professionals (equity)</th>\n",
       "      <th>Patients (equity)</th>\n",
       "      <th>Patient Families (equity)</th>\n",
       "      <th>Equity Benefits Description</th>\n",
       "      <th>Additional Funding Achieved</th>\n",
       "      <th>First AFS Status</th>\n",
       "      <th>First AFS Name and Project Title</th>\n",
       "      <th>First AFS Amount</th>\n",
       "      <th>Second AFS Status</th>\n",
       "      <th>Second AFS Name and Project Title</th>\n",
       "      <th>Second AFS Amount</th>\n",
       "      <th>Third AFS Status</th>\n",
       "      <th>Third AFS Name and Project Title</th>\n",
       "      <th>Third AGS Amount</th>\n",
       "      <th>Fourth AFS Status</th>\n",
       "      <th>Fourth AFS Name and Project Title</th>\n",
       "      <th>Fourth AFS Amount</th>\n",
       "      <th>Additional Funding Source #5 Agency/Sponsor Name and Project Title</th>\n",
       "      <th>Fifth AFS Status</th>\n",
       "      <th>Fifth AFS Amount</th>\n",
       "      <th>Additional Pedal Funding Impact</th>\n",
       "      <th>Additional Funding Benefits Description</th>\n",
       "      <th>Additional Pedal Funding Impact (clinical stages)</th>\n",
       "      <th>Additional Funding Benefits Description (clinical stages)</th>\n",
       "      <th>Participated in Pedal</th>\n",
       "      <th>Further Research Contributions</th>\n",
       "      <th>Success Stories</th>\n",
       "      <th>Major Scientific Breakthroughs</th>\n",
       "      <th>Additional Comments</th>\n",
       "      <th>Complete</th>\n",
       "      <th>Publication Status 1</th>\n",
       "      <th>First DOI #</th>\n",
       "      <th>Publication Status 2</th>\n",
       "      <th>Second DOI #</th>\n",
       "      <th>Publication Status 3</th>\n",
       "      <th>Third DOI #</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>NIH R35HG011315 Using genomic perturbations to...</td>\n",
       "      <td>1500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the applicatio...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>In addition, funding could allow us to do more...</td>\n",
       "      <td>Yes, I have participated as a rider every year...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>4.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Tower Cancer Research Foundation</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>500000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None to date</td>\n",
       "      <td>additional funding provided by Padres Pedal th...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>The combination of cabozantinib with 13-cis-re...</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Exelixis, Inc.</td>\n",
       "      <td>250000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to e...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Funding from Padres Pedal the Cause has been i...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>See above in the progress report.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>Oral cancer prevention and the consequent redu...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>At risk oral cancer patients are often part of...</td>\n",
       "      <td>One</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>NIH R01, will likely be funded soon</td>\n",
       "      <td>2500000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>For advancing the planned clinical trial and c...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Identification of biomarkers predicting clinic...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Many thanks for all your support!!!</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>8.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...</td>\n",
       "      <td>2019-present Member, Wnt Signaling in Prostate...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>Trial focused on all demographic of prostate c...</td>\n",
       "      <td>One</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Oncternal</td>\n",
       "      <td>377000.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>This is a grass roots project. It is a single ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, runner.</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>132.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding would enable the continued ...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, I have participated as a virtual rider ev...</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Accepted</td>\n",
       "      <td>doi.org/10.1093/nar/gkab621</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>133.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Not applicable</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>134.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>136.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No additional funding sources</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funds would enable our team to cont...</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes, in May 2021 I participated virtually.</td>\n",
       "      <td>No</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>138.0</td>\n",
       "      <td>Progress Report #1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Adam K. Fuhs S, Meisenhelder J,  Lesperan...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Yes</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>No</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Five</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>the Hartwell Foundation</td>\n",
       "      <td>300000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Awarded</td>\n",
       "      <td>Padres Pedal the Cause</td>\n",
       "      <td>100000.0</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>Pediatric Cancer Research Foundation</td>\n",
       "      <td>750000.0</td>\n",
       "      <td>NIH R03CA273629-01</td>\n",
       "      <td>Submitted</td>\n",
       "      <td>150000.0</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>Additional funding support would allow us to p...</td>\n",
       "      <td>I have participated as both a virtual particip...</td>\n",
       "      <td>Yes</td>\n",
       "      <td>No</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Funding from Padres Pedal the Cause has  been ...</td>\n",
       "      <td>True</td>\n",
       "      <td>Published</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In progress</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>102 rows × 85 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        ID          Event Name Publication Status 4 Fourth DOI #  \\\n",
       "0      3.0  Progress Report #1                  NaN          NaN   \n",
       "1      4.0  Progress Report #1                  NaN          NaN   \n",
       "2      5.0  Progress Report #1                  NaN          NaN   \n",
       "3      6.0  Progress Report #1                  NaN          NaN   \n",
       "4      8.0  Progress Report #1                  NaN          NaN   \n",
       "..     ...                 ...                  ...          ...   \n",
       "98   132.0  Progress Report #1                  NaN          NaN   \n",
       "99   133.0  Progress Report #1                  NaN          NaN   \n",
       "100  134.0  Progress Report #1                  NaN          NaN   \n",
       "101  136.0  Progress Report #1                  NaN          NaN   \n",
       "102  138.0  Progress Report #1                  NaN          NaN   \n",
       "\n",
       "    Publication Status 5 Fifth DOI # Publication Status 6 Sixth DOI #  \\\n",
       "0                    NaN         NaN                  NaN         NaN   \n",
       "1                    NaN         NaN                  NaN         NaN   \n",
       "2                    NaN         NaN                  NaN         NaN   \n",
       "3                    NaN         NaN                  NaN         NaN   \n",
       "4                    NaN         NaN                  NaN         NaN   \n",
       "..                   ...         ...                  ...         ...   \n",
       "98                   NaN         NaN                  NaN         NaN   \n",
       "99                   NaN         NaN                  NaN         NaN   \n",
       "100                  NaN         NaN                  NaN         NaN   \n",
       "101                  NaN         NaN                  NaN         NaN   \n",
       "102                  NaN         NaN                  NaN         NaN   \n",
       "\n",
       "    Publication Status 7 Seventh DOI # Publication Status 8 Eighth DOI #  \\\n",
       "0                    NaN           NaN                  NaN          NaN   \n",
       "1                    NaN           NaN                  NaN          NaN   \n",
       "2                    NaN           NaN                  NaN          NaN   \n",
       "3                    NaN           NaN                  NaN          NaN   \n",
       "4                    NaN           NaN                  NaN          NaN   \n",
       "..                   ...           ...                  ...          ...   \n",
       "98                   NaN           NaN                  NaN          NaN   \n",
       "99                   NaN           NaN                  NaN          NaN   \n",
       "100                  NaN           NaN                  NaN          NaN   \n",
       "101                  NaN           NaN                  NaN          NaN   \n",
       "102                  NaN           NaN                  NaN          NaN   \n",
       "\n",
       "    Publication Status 9 Ninth DOI # Publication Status 10 Tenth DOI #  \\\n",
       "0                    NaN         NaN                   NaN         NaN   \n",
       "1                    NaN         NaN                   NaN         NaN   \n",
       "2                    NaN         NaN                   NaN         NaN   \n",
       "3                    NaN         NaN                   NaN         NaN   \n",
       "4                    NaN         NaN                   NaN         NaN   \n",
       "..                   ...         ...                   ...         ...   \n",
       "98                   NaN         NaN                   NaN         NaN   \n",
       "99                   NaN         NaN                   NaN         NaN   \n",
       "100                  NaN         NaN                   NaN         NaN   \n",
       "101                  NaN         NaN                   NaN         NaN   \n",
       "102                  NaN         NaN                   NaN         NaN   \n",
       "\n",
       "                                   Pedal Non-Peer Pubs  \\\n",
       "0                                                  NaN   \n",
       "1         Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "2                                         None to date   \n",
       "3                                                  NaN   \n",
       "4    8.Ghali F, Patel D, Jamieson C, Parsons JK, Mc...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102       Adam K. Fuhs S, Meisenhelder J,  Lesperan...   \n",
       "\n",
       "                                 Other Accomplishments Health Benefits  \\\n",
       "0                                                  NaN             Yes   \n",
       "1                                                  NaN             Yes   \n",
       "2    additional funding provided by Padres Pedal th...             Yes   \n",
       "3                    See above in the progress report.             Yes   \n",
       "4    2019-present Member, Wnt Signaling in Prostate...             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN             Yes   \n",
       "99                                      Not applicable             Yes   \n",
       "100                                                NaN             Yes   \n",
       "101                                                NaN             Yes   \n",
       "102                                                NaN             Yes   \n",
       "\n",
       "     International  National  Local  General Public  Healthcare Professionals  \\\n",
       "0            False     False  False           False                     False   \n",
       "1             True     False  False           False                     False   \n",
       "2             True     False  False           False                     False   \n",
       "3             True      True  False           False                     False   \n",
       "4            False     False  False           False                     False   \n",
       "..             ...       ...    ...             ...                       ...   \n",
       "98           False     False  False           False                     False   \n",
       "99           False     False  False           False                     False   \n",
       "100          False     False  False           False                     False   \n",
       "101          False     False  False           False                     False   \n",
       "102           True     False  False           False                     False   \n",
       "\n",
       "     Patients  Patient Families  Policy Influence  International (pol)  \\\n",
       "0        True             False              True                False   \n",
       "1       False             False              True                False   \n",
       "2       False             False              True                False   \n",
       "3        True              True              True                False   \n",
       "4        True             False              True                False   \n",
       "..        ...               ...               ...                  ...   \n",
       "98       True             False              True                False   \n",
       "99       True             False              True                False   \n",
       "100      True             False              True                False   \n",
       "101      True             False              True                False   \n",
       "102     False             False              True                False   \n",
       "\n",
       "     National (pol)  Local (pol)  General Public (pol)  \\\n",
       "0             False        False                 False   \n",
       "1             False        False                 False   \n",
       "2             False        False                 False   \n",
       "3             False        False                 False   \n",
       "4             False        False                 False   \n",
       "..              ...          ...                   ...   \n",
       "98            False        False                 False   \n",
       "99            False        False                 False   \n",
       "100           False        False                 False   \n",
       "101           False        False                 False   \n",
       "102           False        False                 False   \n",
       "\n",
       "     Healthcare Professionals (pol)  Patients (pol)  Patient Families (pol)  \\\n",
       "0                             False           False                   False   \n",
       "1                             False           False                   False   \n",
       "2                             False           False                   False   \n",
       "3                             False           False                   False   \n",
       "4                             False           False                   False   \n",
       "..                              ...             ...                     ...   \n",
       "98                            False           False                   False   \n",
       "99                            False           False                   False   \n",
       "100                           False           False                   False   \n",
       "101                           False           False                   False   \n",
       "102                           False           False                   False   \n",
       "\n",
       "    Policy Benefits Description Economic Benefits  International (econ)  \\\n",
       "0                           NaN                No                 False   \n",
       "1                           NaN                No                 False   \n",
       "2                           NaN               Yes                 False   \n",
       "3                           NaN               Yes                  True   \n",
       "4                           NaN                No                 False   \n",
       "..                          ...               ...                   ...   \n",
       "98                          NaN                No                 False   \n",
       "99                          NaN                No                 False   \n",
       "100                         NaN                No                 False   \n",
       "101                         NaN                No                 False   \n",
       "102                         NaN                No                 False   \n",
       "\n",
       "     National (econ)  Local (econ)  General Public (econ)  \\\n",
       "0              False         False                  False   \n",
       "1              False         False                  False   \n",
       "2               True         False                  False   \n",
       "3               True         False                  False   \n",
       "4              False         False                  False   \n",
       "..               ...           ...                    ...   \n",
       "98             False         False                  False   \n",
       "99             False         False                  False   \n",
       "100            False         False                  False   \n",
       "101            False         False                  False   \n",
       "102            False         False                  False   \n",
       "\n",
       "     Healthcare Professionals (econ)  Patients (econ)  \\\n",
       "0                              False            False   \n",
       "1                              False            False   \n",
       "2                              False            False   \n",
       "3                              False             True   \n",
       "4                              False            False   \n",
       "..                               ...              ...   \n",
       "98                             False            False   \n",
       "99                             False            False   \n",
       "100                            False            False   \n",
       "101                            False            False   \n",
       "102                            False            False   \n",
       "\n",
       "     Patient Families (econ)  \\\n",
       "0                      False   \n",
       "1                      False   \n",
       "2                      False   \n",
       "3                       True   \n",
       "4                      False   \n",
       "..                       ...   \n",
       "98                     False   \n",
       "99                     False   \n",
       "100                    False   \n",
       "101                    False   \n",
       "102                    False   \n",
       "\n",
       "                         Economic Benefits Description Equity Benefits  \\\n",
       "0                                                  NaN              No   \n",
       "1                                                  NaN              No   \n",
       "2    The combination of cabozantinib with 13-cis-re...              No   \n",
       "3    Oral cancer prevention and the consequent redu...             Yes   \n",
       "4                                                  NaN             Yes   \n",
       "..                                                 ...             ...   \n",
       "98                                                 NaN              No   \n",
       "99                                                 NaN              No   \n",
       "100                                                NaN              No   \n",
       "101                                                NaN              No   \n",
       "102                                                NaN              No   \n",
       "\n",
       "     International (equity)  National (equity)  Local (equity)  \\\n",
       "0                     False              False           False   \n",
       "1                     False              False           False   \n",
       "2                     False              False           False   \n",
       "3                      True               True           False   \n",
       "4                     False              False           False   \n",
       "..                      ...                ...             ...   \n",
       "98                    False              False           False   \n",
       "99                    False              False           False   \n",
       "100                   False              False           False   \n",
       "101                   False              False           False   \n",
       "102                   False              False           False   \n",
       "\n",
       "     General Public (equity)  Healthcare Professionals (equity)  \\\n",
       "0                      False                              False   \n",
       "1                      False                              False   \n",
       "2                      False                              False   \n",
       "3                      False                              False   \n",
       "4                      False                              False   \n",
       "..                       ...                                ...   \n",
       "98                     False                              False   \n",
       "99                     False                              False   \n",
       "100                    False                              False   \n",
       "101                    False                              False   \n",
       "102                    False                              False   \n",
       "\n",
       "     Patients (equity)  Patient Families (equity)  \\\n",
       "0                False                      False   \n",
       "1                False                      False   \n",
       "2                False                      False   \n",
       "3                 True                       True   \n",
       "4                 True                      False   \n",
       "..                 ...                        ...   \n",
       "98               False                      False   \n",
       "99               False                      False   \n",
       "100              False                      False   \n",
       "101              False                      False   \n",
       "102              False                      False   \n",
       "\n",
       "                           Equity Benefits Description  \\\n",
       "0                                                  NaN   \n",
       "1                                                  NaN   \n",
       "2                                                  NaN   \n",
       "3    At risk oral cancer patients are often part of...   \n",
       "4    Trial focused on all demographic of prostate c...   \n",
       "..                                                 ...   \n",
       "98                                                 NaN   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101                                                NaN   \n",
       "102                                                NaN   \n",
       "\n",
       "       Additional Funding Achieved First AFS Status  \\\n",
       "0                              One          Awarded   \n",
       "1                             Five          Awarded   \n",
       "2                              One          Awarded   \n",
       "3                              One        Submitted   \n",
       "4                              One          Awarded   \n",
       "..                             ...              ...   \n",
       "98   No additional funding sources              NaN   \n",
       "99   No additional funding sources              NaN   \n",
       "100  No additional funding sources              NaN   \n",
       "101  No additional funding sources              NaN   \n",
       "102                           Five          Awarded   \n",
       "\n",
       "                      First AFS Name and Project Title  First AFS Amount  \\\n",
       "0    NIH R35HG011315 Using genomic perturbations to...         1500000.0   \n",
       "1                              the Hartwell Foundation          300000.0   \n",
       "2                                       Exelixis, Inc.          250000.0   \n",
       "3                  NIH R01, will likely be funded soon         2500000.0   \n",
       "4                                           Oncternal           377000.0   \n",
       "..                                                 ...               ...   \n",
       "98                                                 NaN               NaN   \n",
       "99                                                 NaN               NaN   \n",
       "100                                                NaN               NaN   \n",
       "101                                                NaN               NaN   \n",
       "102                            the Hartwell Foundation          300000.0   \n",
       "\n",
       "    Second AFS Status Second AFS Name and Project Title  Second AFS Amount  \\\n",
       "0                 NaN                               NaN                NaN   \n",
       "1             Awarded            Padres Pedal the Cause           100000.0   \n",
       "2                 NaN                               NaN                NaN   \n",
       "3                 NaN                               NaN                NaN   \n",
       "4                 NaN                               NaN                NaN   \n",
       "..                ...                               ...                ...   \n",
       "98                NaN                               NaN                NaN   \n",
       "99                NaN                               NaN                NaN   \n",
       "100               NaN                               NaN                NaN   \n",
       "101               NaN                               NaN                NaN   \n",
       "102           Awarded            Padres Pedal the Cause           100000.0   \n",
       "\n",
       "    Third AFS Status      Third AFS Name and Project Title  Third AGS Amount  \\\n",
       "0                NaN                                   NaN               NaN   \n",
       "1          Submitted  Pediatric Cancer Research Foundation          750000.0   \n",
       "2                NaN                                   NaN               NaN   \n",
       "3                NaN                                   NaN               NaN   \n",
       "4                NaN                                   NaN               NaN   \n",
       "..               ...                                   ...               ...   \n",
       "98               NaN                                   NaN               NaN   \n",
       "99               NaN                                   NaN               NaN   \n",
       "100              NaN                                   NaN               NaN   \n",
       "101              NaN                                   NaN               NaN   \n",
       "102          Awarded                Padres Pedal the Cause          100000.0   \n",
       "\n",
       "    Fourth AFS Status     Fourth AFS Name and Project Title  \\\n",
       "0                 NaN                                   NaN   \n",
       "1           Submitted                    NIH R03CA273629-01   \n",
       "2                 NaN                                   NaN   \n",
       "3                 NaN                                   NaN   \n",
       "4                 NaN                                   NaN   \n",
       "..                ...                                   ...   \n",
       "98                NaN                                   NaN   \n",
       "99                NaN                                   NaN   \n",
       "100               NaN                                   NaN   \n",
       "101               NaN                                   NaN   \n",
       "102         Submitted  Pediatric Cancer Research Foundation   \n",
       "\n",
       "     Fourth AFS Amount  \\\n",
       "0                  NaN   \n",
       "1             150000.0   \n",
       "2                  NaN   \n",
       "3                  NaN   \n",
       "4                  NaN   \n",
       "..                 ...   \n",
       "98                 NaN   \n",
       "99                 NaN   \n",
       "100                NaN   \n",
       "101                NaN   \n",
       "102           750000.0   \n",
       "\n",
       "    Additional Funding Source #5 Agency/Sponsor Name and Project Title  \\\n",
       "0                                                  NaN                   \n",
       "1                     Tower Cancer Research Foundation                   \n",
       "2                                                  NaN                   \n",
       "3                                                  NaN                   \n",
       "4                                                  NaN                   \n",
       "..                                                 ...                   \n",
       "98                                                 NaN                   \n",
       "99                                                 NaN                   \n",
       "100                                                NaN                   \n",
       "101                                                NaN                   \n",
       "102                                 NIH R03CA273629-01                   \n",
       "\n",
       "    Fifth AFS Status  Fifth AFS Amount Additional Pedal Funding Impact  \\\n",
       "0                NaN               NaN                             Yes   \n",
       "1          Submitted          500000.0                             Yes   \n",
       "2                NaN               NaN                             Yes   \n",
       "3                NaN               NaN                             Yes   \n",
       "4                NaN               NaN                             Yes   \n",
       "..               ...               ...                             ...   \n",
       "98               NaN               NaN                             Yes   \n",
       "99               NaN               NaN                              No   \n",
       "100              NaN               NaN                              No   \n",
       "101              NaN               NaN                             Yes   \n",
       "102        Submitted          150000.0                             Yes   \n",
       "\n",
       "               Additional Funding Benefits Description  \\\n",
       "0    Additional funding would enable the applicatio...   \n",
       "1    Additional funding support would allow us to p...   \n",
       "2    Additional funding support would allow us to e...   \n",
       "3    For advancing the planned clinical trial and c...   \n",
       "4    This is a grass roots project. It is a single ...   \n",
       "..                                                 ...   \n",
       "98   Additional funding would enable the continued ...   \n",
       "99                                                 NaN   \n",
       "100                                                NaN   \n",
       "101  Additional funds would enable our team to cont...   \n",
       "102  Additional funding support would allow us to p...   \n",
       "\n",
       "    Additional Pedal Funding Impact (clinical stages)  \\\n",
       "0                                                 Yes   \n",
       "1                                                 Yes   \n",
       "2                                                 Yes   \n",
       "3                                                 Yes   \n",
       "4                                                  No   \n",
       "..                                                ...   \n",
       "98                                                 No   \n",
       "99                                                 No   \n",
       "100                                                No   \n",
       "101                                                No   \n",
       "102                                               Yes   \n",
       "\n",
       "    Additional Funding Benefits Description (clinical stages)  \\\n",
       "0    In addition, funding could allow us to do more...          \n",
       "1    Additional funding support would allow us to p...          \n",
       "2    Additional funding support would allow us to p...          \n",
       "3    Identification of biomarkers predicting clinic...          \n",
       "4                                                  NaN          \n",
       "..                                                 ...          \n",
       "98                                                 NaN          \n",
       "99                                                 NaN          \n",
       "100                                                NaN          \n",
       "101                                                NaN          \n",
       "102  Additional funding support would allow us to p...          \n",
       "\n",
       "                                 Participated in Pedal  \\\n",
       "0    Yes, I have participated as a rider every year...   \n",
       "1    I have participated as both a virtual particip...   \n",
       "2    I have participated as both a virtual particip...   \n",
       "3                                                  Yes   \n",
       "4                                        Yes, runner.    \n",
       "..                                                 ...   \n",
       "98   Yes, I have participated as a virtual rider ev...   \n",
       "99                                                  No   \n",
       "100                                                NaN   \n",
       "101         Yes, in May 2021 I participated virtually.   \n",
       "102  I have participated as both a virtual particip...   \n",
       "\n",
       "    Further Research Contributions Success Stories  \\\n",
       "0                               No              No   \n",
       "1                              Yes              No   \n",
       "2                              Yes             Yes   \n",
       "3                               No              No   \n",
       "4                              Yes              No   \n",
       "..                             ...             ...   \n",
       "98                              No              No   \n",
       "99                              No              No   \n",
       "100                            NaN             NaN   \n",
       "101                             No              No   \n",
       "102                            Yes              No   \n",
       "\n",
       "    Major Scientific Breakthroughs  \\\n",
       "0                              NaN   \n",
       "1                              NaN   \n",
       "2                              Yes   \n",
       "3                              NaN   \n",
       "4                              NaN   \n",
       "..                             ...   \n",
       "98                             NaN   \n",
       "99                             NaN   \n",
       "100                            NaN   \n",
       "101                            NaN   \n",
       "102                            NaN   \n",
       "\n",
       "                                   Additional Comments  Complete  \\\n",
       "0                                                  NaN      True   \n",
       "1    Funding from Padres Pedal the Cause has been i...      True   \n",
       "2    Funding from Padres Pedal the Cause has been i...      True   \n",
       "3                  Many thanks for all your support!!!      True   \n",
       "4                                                  NaN      True   \n",
       "..                                                 ...       ...   \n",
       "98                                                 NaN      True   \n",
       "99                                                  No      True   \n",
       "100                                                NaN      True   \n",
       "101                                                NaN      True   \n",
       "102  Funding from Padres Pedal the Cause has  been ...      True   \n",
       "\n",
       "    Publication Status 1                  First DOI # Publication Status 2  \\\n",
       "0               Accepted                          NaN                  NaN   \n",
       "1               Accepted                          NaN            Submitted   \n",
       "2              Published                          NaN                  NaN   \n",
       "3            In progress                          NaN          In progress   \n",
       "4                    NaN                          NaN                  NaN   \n",
       "..                   ...                          ...                  ...   \n",
       "98              Accepted  doi.org/10.1093/nar/gkab621          In progress   \n",
       "99           In progress                          NaN                  NaN   \n",
       "100            Published                          NaN                  NaN   \n",
       "101          In progress                          NaN                  NaN   \n",
       "102            Published                          NaN          In progress   \n",
       "\n",
       "    Second DOI # Publication Status 3 Third DOI #  \n",
       "0            NaN                  NaN         NaN  \n",
       "1            NaN                  NaN         NaN  \n",
       "2            NaN                  NaN         NaN  \n",
       "3            NaN                  NaN         NaN  \n",
       "4            NaN                  NaN         NaN  \n",
       "..           ...                  ...         ...  \n",
       "98           NaN                  NaN         NaN  \n",
       "99           NaN                  NaN         NaN  \n",
       "100          NaN                  NaN         NaN  \n",
       "101          NaN                  NaN         NaN  \n",
       "102          NaN                  NaN         NaN  \n",
       "\n",
       "[102 rows x 85 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pr['Policy Influence'] = pr['Policy Influence'].fillna(False).astype(bool)\n",
    "\n",
    "pr[pr['Policy Influence']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Published      30\n",
      "In progress    28\n",
      "Accepted       16\n",
      "Submitted       2\n",
      "Name: Publication Status 1, dtype: int64\n",
      "\n",
      "In progress    21\n",
      "Published      11\n",
      "Submitted       5\n",
      "Accepted        4\n",
      "Name: Publication Status 2, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    5\n",
      "Accepted       3\n",
      "Submitted      1\n",
      "Name: Publication Status 3, dtype: int64\n",
      "\n",
      "Published      6\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Name: Publication Status 4, dtype: int64\n",
      "\n",
      "Accepted     2\n",
      "Published    2\n",
      "Submitted    1\n",
      "Name: Publication Status 5, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 6, dtype: int64\n",
      "\n",
      "Submitted    2\n",
      "Accepted     1\n",
      "Published    1\n",
      "Name: Publication Status 7, dtype: int64\n",
      "\n",
      "Accepted       1\n",
      "Submitted      1\n",
      "In progress    1\n",
      "Published      1\n",
      "Name: Publication Status 8, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 9, dtype: int64\n",
      "\n",
      "In progress    2\n",
      "Accepted       1\n",
      "Published      1\n",
      "Name: Publication Status 10, dtype: int64\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for i in range(1, 11):\n",
    "    print(pr[f'Publication Status {i}'].value_counts())\n",
    "    print()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Published      30\n",
       "In progress    28\n",
       "Accepted       16\n",
       "Submitted       2\n",
       "Name: Publication Status 1, dtype: int64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "to_plot = pr['Publication Status 1'].value_counts()\n",
    "to_plot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.plotly.v1+json": {
       "config": {
        "plotlyServerURL": "https://plot.ly"
       },
       "data": [
        {
         "alignmentgroup": "True",
         "hovertemplate": "variable=Publication Status 1<br>index=%{x}<br>value=%{y}<extra></extra>",
         "legendgroup": "Publication Status 1",
         "marker": {
          "color": "#636efa",
          "pattern": {
           "shape": ""
          }
         },
         "name": "Publication Status 1",
         "offsetgroup": "Publication Status 1",
         "orientation": "v",
         "showlegend": true,
         "textposition": "auto",
         "type": "bar",
         "x": [
          "Published",
          "In progress",
          "Accepted",
          "Submitted"
         ],
         "xaxis": "x",
         "y": [
          30,
          28,
          16,
          2
         ],
         "yaxis": "y"
        }
       ],
       "layout": {
        "barmode": "relative",
        "legend": {
         "title": {
          "text": "variable"
         },
         "tracegroupgap": 0
        },
        "margin": {
         "t": 60
        },
        "template": {
         "data": {
          "bar": [
           {
            "error_x": {
             "color": "#2a3f5f"
            },
            "error_y": {
             "color": "#2a3f5f"
            },
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "bar"
           }
          ],
          "barpolar": [
           {
            "marker": {
             "line": {
              "color": "#E5ECF6",
              "width": 0.5
             },
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "barpolar"
           }
          ],
          "carpet": [
           {
            "aaxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "baxis": {
             "endlinecolor": "#2a3f5f",
             "gridcolor": "white",
             "linecolor": "white",
             "minorgridcolor": "white",
             "startlinecolor": "#2a3f5f"
            },
            "type": "carpet"
           }
          ],
          "choropleth": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "choropleth"
           }
          ],
          "contour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "contour"
           }
          ],
          "contourcarpet": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "contourcarpet"
           }
          ],
          "heatmap": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmap"
           }
          ],
          "heatmapgl": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "heatmapgl"
           }
          ],
          "histogram": [
           {
            "marker": {
             "pattern": {
              "fillmode": "overlay",
              "size": 10,
              "solidity": 0.2
             }
            },
            "type": "histogram"
           }
          ],
          "histogram2d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2d"
           }
          ],
          "histogram2dcontour": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "histogram2dcontour"
           }
          ],
          "mesh3d": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "type": "mesh3d"
           }
          ],
          "parcoords": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "parcoords"
           }
          ],
          "pie": [
           {
            "automargin": true,
            "type": "pie"
           }
          ],
          "scatter": [
           {
            "fillpattern": {
             "fillmode": "overlay",
             "size": 10,
             "solidity": 0.2
            },
            "type": "scatter"
           }
          ],
          "scatter3d": [
           {
            "line": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatter3d"
           }
          ],
          "scattercarpet": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattercarpet"
           }
          ],
          "scattergeo": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergeo"
           }
          ],
          "scattergl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattergl"
           }
          ],
          "scattermapbox": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scattermapbox"
           }
          ],
          "scatterpolar": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolar"
           }
          ],
          "scatterpolargl": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterpolargl"
           }
          ],
          "scatterternary": [
           {
            "marker": {
             "colorbar": {
              "outlinewidth": 0,
              "ticks": ""
             }
            },
            "type": "scatterternary"
           }
          ],
          "surface": [
           {
            "colorbar": {
             "outlinewidth": 0,
             "ticks": ""
            },
            "colorscale": [
             [
              0,
              "#0d0887"
             ],
             [
              0.1111111111111111,
              "#46039f"
             ],
             [
              0.2222222222222222,
              "#7201a8"
             ],
             [
              0.3333333333333333,
              "#9c179e"
             ],
             [
              0.4444444444444444,
              "#bd3786"
             ],
             [
              0.5555555555555556,
              "#d8576b"
             ],
             [
              0.6666666666666666,
              "#ed7953"
             ],
             [
              0.7777777777777778,
              "#fb9f3a"
             ],
             [
              0.8888888888888888,
              "#fdca26"
             ],
             [
              1,
              "#f0f921"
             ]
            ],
            "type": "surface"
           }
          ],
          "table": [
           {
            "cells": {
             "fill": {
              "color": "#EBF0F8"
             },
             "line": {
              "color": "white"
             }
            },
            "header": {
             "fill": {
              "color": "#C8D4E3"
             },
             "line": {
              "color": "white"
             }
            },
            "type": "table"
           }
          ]
         },
         "layout": {
          "annotationdefaults": {
           "arrowcolor": "#2a3f5f",
           "arrowhead": 0,
           "arrowwidth": 1
          },
          "autotypenumbers": "strict",
          "coloraxis": {
           "colorbar": {
            "outlinewidth": 0,
            "ticks": ""
           }
          },
          "colorscale": {
           "diverging": [
            [
             0,
             "#8e0152"
            ],
            [
             0.1,
             "#c51b7d"
            ],
            [
             0.2,
             "#de77ae"
            ],
            [
             0.3,
             "#f1b6da"
            ],
            [
             0.4,
             "#fde0ef"
            ],
            [
             0.5,
             "#f7f7f7"
            ],
            [
             0.6,
             "#e6f5d0"
            ],
            [
             0.7,
             "#b8e186"
            ],
            [
             0.8,
             "#7fbc41"
            ],
            [
             0.9,
             "#4d9221"
            ],
            [
             1,
             "#276419"
            ]
           ],
           "sequential": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ],
           "sequentialminus": [
            [
             0,
             "#0d0887"
            ],
            [
             0.1111111111111111,
             "#46039f"
            ],
            [
             0.2222222222222222,
             "#7201a8"
            ],
            [
             0.3333333333333333,
             "#9c179e"
            ],
            [
             0.4444444444444444,
             "#bd3786"
            ],
            [
             0.5555555555555556,
             "#d8576b"
            ],
            [
             0.6666666666666666,
             "#ed7953"
            ],
            [
             0.7777777777777778,
             "#fb9f3a"
            ],
            [
             0.8888888888888888,
             "#fdca26"
            ],
            [
             1,
             "#f0f921"
            ]
           ]
          },
          "colorway": [
           "#636efa",
           "#EF553B",
           "#00cc96",
           "#ab63fa",
           "#FFA15A",
           "#19d3f3",
           "#FF6692",
           "#B6E880",
           "#FF97FF",
           "#FECB52"
          ],
          "font": {
           "color": "#2a3f5f"
          },
          "geo": {
           "bgcolor": "white",
           "lakecolor": "white",
           "landcolor": "#E5ECF6",
           "showlakes": true,
           "showland": true,
           "subunitcolor": "white"
          },
          "hoverlabel": {
           "align": "left"
          },
          "hovermode": "closest",
          "mapbox": {
           "style": "light"
          },
          "paper_bgcolor": "white",
          "plot_bgcolor": "#E5ECF6",
          "polar": {
           "angularaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "radialaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "scene": {
           "xaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "yaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           },
           "zaxis": {
            "backgroundcolor": "#E5ECF6",
            "gridcolor": "white",
            "gridwidth": 2,
            "linecolor": "white",
            "showbackground": true,
            "ticks": "",
            "zerolinecolor": "white"
           }
          },
          "shapedefaults": {
           "line": {
            "color": "#2a3f5f"
           }
          },
          "ternary": {
           "aaxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "baxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           },
           "bgcolor": "#E5ECF6",
           "caxis": {
            "gridcolor": "white",
            "linecolor": "white",
            "ticks": ""
           }
          },
          "title": {
           "x": 0.05
          },
          "xaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          },
          "yaxis": {
           "automargin": true,
           "gridcolor": "white",
           "linecolor": "white",
           "ticks": "",
           "title": {
            "standoff": 15
           },
           "zerolinecolor": "white",
           "zerolinewidth": 2
          }
         }
        },
        "xaxis": {
         "anchor": "y",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "index"
         }
        },
        "yaxis": {
         "anchor": "x",
         "domain": [
          0,
          1
         ],
         "title": {
          "text": "value"
         }
        }
       }
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "px.bar(to_plot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.2"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
